id	sid	tid	token	lemma	pos
dpc-4097	1	1	dermatology	dermatology	NOUN
dpc-4097	1	2	:	:	PUNCT
dpc-4097	1	3	practical	practical	ADJ
dpc-4097	1	4	and	and	CCONJ
dpc-4097	1	5	conceptual	conceptual	ADJ
dpc-4097	1	6	original	original	ADJ
dpc-4097	1	7	article	article	NOUN
dpc-4097	1	8	|	|	ADV
dpc-4097	1	9	dermatol	dermatol	ADJ
dpc-4097	1	10	pract	pract	NOUN
dpc-4097	1	11	concept	concept	NOUN
dpc-4097	1	12	.	.	PUNCT
dpc-4097	2	1	2024;14(3):e2024171	2024;14(3):e2024171	NUM
dpc-4097	2	2	1	1	NUM
dpc-4097	2	3	psoriasis	psoriasis	NOUN
dpc-4097	2	4	with	with	ADP
dpc-4097	2	5	leg	leg	NOUN
dpc-4097	2	6	involvement	involvement	NOUN
dpc-4097	2	7	as	as	ADP
dpc-4097	2	8	the	the	DET
dpc-4097	2	9	new	new	ADJ
dpc-4097	2	10	difficult	difficult	ADJ
dpc-4097	2	11	-	-	PUNCT
dpc-4097	2	12	to	to	ADP
dpc-4097	2	13	-	-	PUNCT
dpc-4097	2	14	treat	treat	NOUN
dpc-4097	2	15	area	area	NOUN
dpc-4097	2	16	:	:	PUNCT
dpc-4097	2	17	a	a	DET
dpc-4097	2	18	cohort	cohort	NOUN
dpc-4097	2	19	study	study	NOUN
dpc-4097	2	20	of	of	ADP
dpc-4097	2	21	patients	patient	NOUN
dpc-4097	2	22	treated	treat	VERB
dpc-4097	2	23	with	with	ADP
dpc-4097	2	24	risankizumab	risankizumab	PROPN
dpc-4097	2	25	federico	federico	PROPN
dpc-4097	2	26	bardazzi1,2	bardazzi1,2	PROPN
dpc-4097	2	27	,	,	PUNCT
dpc-4097	2	28	federica	federica	PROPN
dpc-4097	2	29	filippi1,2	filippi1,2	PROPN
dpc-4097	2	30	,	,	PUNCT
dpc-4097	2	31	martina	martina	PROPN
dpc-4097	2	32	mussi1,2	mussi1,2	PROPN
dpc-4097	2	33	,	,	PUNCT
dpc-4097	2	34	claudia	claudia	PROPN
dpc-4097	2	35	lasagni3	lasagni3	PROPN
dpc-4097	2	36	,	,	PUNCT
dpc-4097	2	37	laura	laura	PROPN
dpc-4097	2	38	bigi3	bigi3	PROPN
dpc-4097	2	39	,	,	PUNCT
dpc-4097	2	40	giulia	giulia	PROPN
dpc-4097	2	41	odorici4	odorici4	PROPN
dpc-4097	2	42	,	,	PUNCT
dpc-4097	2	43	francesca	francesca	PROPN
dpc-4097	2	44	peccerillo5	peccerillo5	PROPN
dpc-4097	2	45	,	,	PUNCT
dpc-4097	2	46	miriam	miriam	PROPN
dpc-4097	2	47	rovesti6	rovesti6	PROPN
dpc-4097	2	48	,	,	PUNCT
dpc-4097	2	49	francesca	francesca	PROPN
dpc-4097	2	50	satolli6	satolli6	PROPN
dpc-4097	2	51	,	,	PUNCT
dpc-4097	2	52	michela	michela	PROPN
dpc-4097	2	53	tabanelli7	tabanelli7	PROPN
dpc-4097	2	54	,	,	PUNCT
dpc-4097	2	55	sandra	sandra	PROPN
dpc-4097	2	56	schianchi8	schianchi8	PROPN
dpc-4097	2	57	,	,	PUNCT
dpc-4097	2	58	vito	vito	PROPN
dpc-4097	2	59	di	di	PROPN
dpc-4097	2	60	lernia9	lernia9	PROPN
dpc-4097	2	61	,	,	PUNCT
dpc-4097	2	62	marco	marco	PROPN
dpc-4097	2	63	manfredini3	manfredini3	PROPN
dpc-4097	2	64	1	1	NUM
dpc-4097	2	65	division	division	NOUN
dpc-4097	2	66	of	of	ADP
dpc-4097	2	67	dermatology	dermatology	NOUN
dpc-4097	2	68	,	,	PUNCT
dpc-4097	2	69	department	department	NOUN
dpc-4097	2	70	of	of	ADP
dpc-4097	2	71	experimental	experimental	ADJ
dpc-4097	2	72	,	,	PUNCT
dpc-4097	2	73	diagnostic	diagnostic	ADJ
dpc-4097	2	74	and	and	CCONJ
dpc-4097	2	75	specialty	specialty	NOUN
dpc-4097	2	76	medicine	medicine	NOUN
dpc-4097	2	77	,	,	PUNCT
dpc-4097	2	78	division	division	NOUN
dpc-4097	2	79	of	of	ADP
dpc-4097	2	80	dermatology	dermatology	NOUN
dpc-4097	2	81	,	,	PUNCT
dpc-4097	2	82	s.	s.	PROPN
dpc-4097	2	83	orsola	orsola	PROPN
dpc-4097	2	84	-	-	PUNCT
dpc-4097	2	85	malpighi	malpighi	PROPN
dpc-4097	2	86	hospital	hospital	NOUN
dpc-4097	2	87	,	,	PUNCT
dpc-4097	2	88	university	university	NOUN
dpc-4097	2	89	of	of	ADP
dpc-4097	2	90	bologna	bologna	NOUN
dpc-4097	2	91	,	,	PUNCT
dpc-4097	2	92	bologna	bologna	PROPN
dpc-4097	2	93	,	,	PUNCT
dpc-4097	2	94	italy	italy	PROPN
dpc-4097	2	95	2	2	NUM
dpc-4097	2	96	division	division	NOUN
dpc-4097	2	97	of	of	ADP
dpc-4097	2	98	dermatology	dermatology	NOUN
dpc-4097	2	99	,	,	PUNCT
dpc-4097	2	100	irccs	irccs	PROPN
dpc-4097	2	101	azienda	azienda	PROPN
dpc-4097	2	102	ospedaliero	ospedaliero	PROPN
dpc-4097	2	103	-	-	PUNCT
dpc-4097	2	104	universitaria	universitaria	PROPN
dpc-4097	2	105	di	di	PROPN
dpc-4097	2	106	bologna	bologna	PROPN
dpc-4097	2	107	,	,	PUNCT
dpc-4097	2	108	bologna	bologna	PROPN
dpc-4097	2	109	,	,	PUNCT
dpc-4097	2	110	italy	italy	PROPN
dpc-4097	2	111	3	3	NUM
dpc-4097	2	112	clinica	clinica	PROPN
dpc-4097	2	113	dermatologica	dermatologica	PROPN
dpc-4097	2	114	,	,	PUNCT
dpc-4097	2	115	dipartimento	dipartimento	ADP
dpc-4097	2	116	delle	delle	NOUN
dpc-4097	2	117	medicine	medicine	NOUN
dpc-4097	2	118	specialistiche	specialistiche	PROPN
dpc-4097	2	119	aou	aou	PROPN
dpc-4097	2	120	policlinico	policlinico	PROPN
dpc-4097	2	121	di	di	PROPN
dpc-4097	2	122	modena	modena	PROPN
dpc-4097	2	123	,	,	PUNCT
dpc-4097	2	124	modena	modena	PROPN
dpc-4097	2	125	,	,	PUNCT
dpc-4097	2	126	italy	italy	PROPN
dpc-4097	2	127	4	4	NUM
dpc-4097	2	128	section	section	NOUN
dpc-4097	2	129	of	of	ADP
dpc-4097	2	130	dermatology	dermatology	NOUN
dpc-4097	2	131	and	and	CCONJ
dpc-4097	2	132	infectious	infectious	ADJ
dpc-4097	2	133	diseases	disease	NOUN
dpc-4097	2	134	,	,	PUNCT
dpc-4097	2	135	department	department	NOUN
dpc-4097	2	136	of	of	ADP
dpc-4097	2	137	medical	medical	ADJ
dpc-4097	2	138	sciences	sciences	PROPN
dpc-4097	2	139	,	,	PUNCT
dpc-4097	2	140	university	university	NOUN
dpc-4097	2	141	of	of	ADP
dpc-4097	2	142	ferrara	ferrara	NOUN
dpc-4097	2	143	,	,	PUNCT
dpc-4097	2	144	ferrara	ferrara	NOUN
dpc-4097	2	145	,	,	PUNCT
dpc-4097	2	146	italy	italy	PROPN
dpc-4097	2	147	5	5	NUM
dpc-4097	2	148	dermatology	dermatology	NOUN
dpc-4097	2	149	unit	unit	NOUN
dpc-4097	2	150	,	,	PUNCT
dpc-4097	2	151	surgical	surgical	ADJ
dpc-4097	2	152	,	,	PUNCT
dpc-4097	2	153	medical	medical	ADJ
dpc-4097	2	154	and	and	CCONJ
dpc-4097	2	155	dental	dental	ADJ
dpc-4097	2	156	department	department	NOUN
dpc-4097	2	157	of	of	ADP
dpc-4097	2	158	morphological	morphological	ADJ
dpc-4097	2	159	sciences	science	NOUN
dpc-4097	2	160	related	relate	VERB
dpc-4097	2	161	to	to	ADP
dpc-4097	2	162	transplant	transplant	NOUN
dpc-4097	2	163	,	,	PUNCT
dpc-4097	2	164	oncology	oncology	NOUN
dpc-4097	2	165	and	and	CCONJ
dpc-4097	2	166	regenerative	regenerative	ADJ
dpc-4097	2	167	medicine	medicine	NOUN
dpc-4097	2	168	,	,	PUNCT
dpc-4097	2	169	university	university	NOUN
dpc-4097	2	170	of	of	ADP
dpc-4097	2	171	modena	modena	PROPN
dpc-4097	2	172	and	and	CCONJ
dpc-4097	2	173	reggio	reggio	PROPN
dpc-4097	2	174	emilia	emilia	PROPN
dpc-4097	2	175	,	,	PUNCT
dpc-4097	2	176	modena	modena	PROPN
dpc-4097	2	177	,	,	PUNCT
dpc-4097	2	178	italy	italy	PROPN
dpc-4097	2	179	6	6	NUM
dpc-4097	2	180	department	department	NOUN
dpc-4097	2	181	of	of	ADP
dpc-4097	2	182	dermatology	dermatology	NOUN
dpc-4097	2	183	,	,	PUNCT
dpc-4097	2	184	university	university	NOUN
dpc-4097	2	185	of	of	ADP
dpc-4097	2	186	parma	parma	PROPN
dpc-4097	2	187	,	,	PUNCT
dpc-4097	2	188	parma	parma	PROPN
dpc-4097	2	189	,	,	PUNCT
dpc-4097	2	190	italy	italy	PROPN
dpc-4097	2	191	7	7	NUM
dpc-4097	2	192	dermatology	dermatology	NOUN
dpc-4097	2	193	unit	unit	NOUN
dpc-4097	2	194	,	,	PUNCT
dpc-4097	2	195	ausl	ausl	PROPN
dpc-4097	2	196	romagna	romagna	PROPN
dpc-4097	2	197	,	,	PUNCT
dpc-4097	2	198	ravenna	ravenna	PROPN
dpc-4097	2	199	,	,	PUNCT
dpc-4097	2	200	italy	italy	PROPN
dpc-4097	2	201	8	8	NUM
dpc-4097	2	202	department	department	PROPN
dpc-4097	2	203	of	of	ADP
dpc-4097	2	204	dermatology	dermatology	NOUN
dpc-4097	2	205	,	,	PUNCT
dpc-4097	2	206	‘	'	PUNCT
dpc-4097	2	207	m	m	NOUN
dpc-4097	2	208	bufalini	bufalini	ADJ
dpc-4097	2	209	’	'	PUNCT
dpc-4097	2	210	hospital	hospital	NOUN
dpc-4097	2	211	,	,	PUNCT
dpc-4097	2	212	cesena	cesena	PROPN
dpc-4097	2	213	,	,	PUNCT
dpc-4097	2	214	italy	italy	PROPN
dpc-4097	2	215	9	9	NUM
dpc-4097	2	216	dermatology	dermatology	NOUN
dpc-4097	2	217	unit	unit	NOUN
dpc-4097	2	218	,	,	PUNCT
dpc-4097	2	219	arcispedale	arcispedale	PROPN
dpc-4097	2	220	santa	santa	PROPN
dpc-4097	2	221	maria	maria	PROPN
dpc-4097	2	222	nuova	nuova	PROPN
dpc-4097	2	223	,	,	PUNCT
dpc-4097	2	224	azienda	azienda	PROPN
dpc-4097	2	225	unità	unità	PROPN
dpc-4097	2	226	sanitaria	sanitaria	PROPN
dpc-4097	2	227	locale	locale	PROPN
dpc-4097	2	228	-	-	PUNCT
dpc-4097	2	229	istituto	istituto	X
dpc-4097	2	230	di	di	X
dpc-4097	2	231	ricovero	ricovero	PROPN
dpc-4097	2	232	e	e	PROPN
dpc-4097	2	233	cura	cura	PROPN
dpc-4097	2	234	a	a	PROPN
dpc-4097	2	235	carattere	carattere	PROPN
dpc-4097	2	236	scientifico	scientifico	PROPN
dpc-4097	2	237	di	di	PROPN
dpc-4097	2	238	reggio	reggio	PROPN
dpc-4097	2	239	emilia	emilia	PROPN
dpc-4097	2	240	,	,	PUNCT
dpc-4097	2	241	reggio	reggio	PROPN
dpc-4097	2	242	emilia	emilia	PROPN
dpc-4097	2	243	,	,	PUNCT
dpc-4097	2	244	italy	italy	PROPN
dpc-4097	2	245	key	key	ADJ
dpc-4097	2	246	words	word	NOUN
dpc-4097	2	247	:	:	PUNCT
dpc-4097	2	248	psoriasis	psoriasis	NOUN
dpc-4097	2	249	,	,	PUNCT
dpc-4097	2	250	difficult	difficult	ADJ
dpc-4097	2	251	-	-	PUNCT
dpc-4097	2	252	to	to	ADP
dpc-4097	2	253	-	-	PUNCT
dpc-4097	2	254	treat	treat	NOUN
dpc-4097	2	255	areas	area	NOUN
dpc-4097	2	256	,	,	PUNCT
dpc-4097	2	257	risankizumab	risankizumab	NOUN
dpc-4097	2	258	,	,	PUNCT
dpc-4097	2	259	biological	biological	ADJ
dpc-4097	2	260	treatment	treatment	NOUN
dpc-4097	2	261	,	,	PUNCT
dpc-4097	2	262	legs	leg	NOUN
dpc-4097	2	263	,	,	PUNCT
dpc-4097	2	264	psoriasis	psoriasis	NOUN
dpc-4097	2	265	citation	citation	NOUN
dpc-4097	2	266	:	:	PUNCT
dpc-4097	2	267	bardazzi	bardazzi	PROPN
dpc-4097	2	268	f	f	PROPN
dpc-4097	2	269	,	,	PUNCT
dpc-4097	2	270	filippi	filippi	PROPN
dpc-4097	2	271	f	f	PROPN
dpc-4097	2	272	,	,	PUNCT
dpc-4097	2	273	mussi	mussi	PROPN
dpc-4097	2	274	m	m	PROPN
dpc-4097	2	275	,	,	PUNCT
dpc-4097	2	276	et	et	PROPN
dpc-4097	2	277	al	al	PROPN
dpc-4097	2	278	.	.	PUNCT
dpc-4097	2	279	psoriasis	psoriasis	NOUN
dpc-4097	2	280	with	with	ADP
dpc-4097	2	281	leg	leg	NOUN
dpc-4097	2	282	involvement	involvement	NOUN
dpc-4097	2	283	as	as	ADP
dpc-4097	2	284	the	the	DET
dpc-4097	2	285	new	new	ADJ
dpc-4097	2	286	difficult	difficult	ADJ
dpc-4097	2	287	-	-	PUNCT
dpc-4097	2	288	to	to	ADP
dpc-4097	2	289	-	-	PUNCT
dpc-4097	2	290	treat	treat	NOUN
dpc-4097	2	291	area	area	NOUN
dpc-4097	2	292	:	:	PUNCT
dpc-4097	2	293	a	a	DET
dpc-4097	2	294	cohort	cohort	NOUN
dpc-4097	2	295	study	study	NOUN
dpc-4097	2	296	of	of	ADP
dpc-4097	2	297	patients	patient	NOUN
dpc-4097	2	298	treated	treat	VERB
dpc-4097	2	299	with	with	ADP
dpc-4097	2	300	risankizumab	risankizumab	NOUN
dpc-4097	2	301	.	.	PUNCT
dpc-4097	3	1	dermatol	dermatol	NOUN
dpc-4097	3	2	pract	pract	PROPN
dpc-4097	3	3	concept	concept	NOUN
dpc-4097	3	4	.	.	PUNCT
dpc-4097	4	1	2024;14(3):e2024171	2024;14(3):e2024171	X
dpc-4097	4	2	.	.	PUNCT
dpc-4097	5	1	doi	doi	PROPN
dpc-4097	5	2	:	:	PUNCT
dpc-4097	5	3	https://doi.org/10.5826/dpc.1403a171	https://doi.org/10.5826/dpc.1403a171	PROPN
dpc-4097	5	4	accepted	accept	VERB
dpc-4097	5	5	:	:	PUNCT
dpc-4097	5	6	march	march	PROPN
dpc-4097	5	7	3	3	NUM
dpc-4097	5	8	,	,	PUNCT
dpc-4097	5	9	2024	2024	NUM
dpc-4097	5	10	;	;	PUNCT
dpc-4097	5	11	published	publish	VERB
dpc-4097	5	12	:	:	PUNCT
dpc-4097	6	1	july	july	PROPN
dpc-4097	6	2	2024	2024	NUM
dpc-4097	6	3	copyright	copyright	NOUN
dpc-4097	6	4	:	:	PUNCT
dpc-4097	6	5	©	©	PROPN
dpc-4097	6	6	2024	2024	NUM
dpc-4097	6	7	bardazzi	bardazzi	NOUN
dpc-4097	6	8	et	et	PROPN
dpc-4097	6	9	al	al	PROPN
dpc-4097	6	10	.	.	PUNCT
dpc-4097	7	1	this	this	PRON
dpc-4097	7	2	is	be	AUX
dpc-4097	7	3	an	an	DET
dpc-4097	7	4	open	open	ADJ
dpc-4097	7	5	-	-	PUNCT
dpc-4097	7	6	access	access	NOUN
dpc-4097	7	7	article	article	NOUN
dpc-4097	7	8	distributed	distribute	VERB
dpc-4097	7	9	under	under	ADP
dpc-4097	7	10	the	the	DET
dpc-4097	7	11	terms	term	NOUN
dpc-4097	7	12	of	of	ADP
dpc-4097	7	13	the	the	DET
dpc-4097	7	14	creative	creative	ADJ
dpc-4097	7	15	commons	common	NOUN
dpc-4097	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4097	7	17	license	license	NOUN
dpc-4097	7	18	(	(	PUNCT
dpc-4097	7	19	by	by	ADP
dpc-4097	7	20	-	-	PUNCT
dpc-4097	7	21	nc-4.0	nc-4.0	NOUN
dpc-4097	7	22	)	)	PUNCT
dpc-4097	7	23	,	,	PUNCT
dpc-4097	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4097	7	25	,	,	PUNCT
dpc-4097	7	26	which	which	PRON
dpc-4097	7	27	permits	permit	VERB
dpc-4097	7	28	unrestricted	unrestricted	ADJ
dpc-4097	7	29	noncommercial	noncommercial	ADJ
dpc-4097	7	30	use	use	NOUN
dpc-4097	7	31	,	,	PUNCT
dpc-4097	7	32	distribution	distribution	NOUN
dpc-4097	7	33	,	,	PUNCT
dpc-4097	7	34	and	and	CCONJ
dpc-4097	7	35	reproduction	reproduction	NOUN
dpc-4097	7	36	in	in	ADP
dpc-4097	7	37	any	any	DET
dpc-4097	7	38	medium	medium	NOUN
dpc-4097	7	39	,	,	PUNCT
dpc-4097	7	40	provided	provide	VERB
dpc-4097	7	41	the	the	DET
dpc-4097	7	42	original	original	ADJ
dpc-4097	7	43	authors	author	NOUN
dpc-4097	7	44	and	and	CCONJ
dpc-4097	7	45	source	source	NOUN
dpc-4097	7	46	are	be	AUX
dpc-4097	7	47	credited	credit	VERB
dpc-4097	7	48	.	.	PUNCT
dpc-4097	8	1	funding	funding	NOUN
dpc-4097	8	2	:	:	PUNCT
dpc-4097	8	3	none	none	NOUN
dpc-4097	8	4	.	.	PUNCT
dpc-4097	9	1	competing	compete	VERB
dpc-4097	9	2	interests	interest	NOUN
dpc-4097	9	3	:	:	PUNCT
dpc-4097	9	4	none	none	NOUN
dpc-4097	9	5	.	.	PUNCT
dpc-4097	10	1	authorship	authorship	NOUN
dpc-4097	10	2	:	:	PUNCT
dpc-4097	10	3	f.	f.	PROPN
dpc-4097	10	4	bonazzi	bonazzi	PROPN
dpc-4097	10	5	and	and	CCONJ
dpc-4097	10	6	f.	f.	PROPN
dpc-4097	10	7	filippi	filippi	PROPN
dpc-4097	10	8	equally	equally	ADV
dpc-4097	10	9	contributed	contribute	VERB
dpc-4097	10	10	to	to	ADP
dpc-4097	10	11	this	this	DET
dpc-4097	10	12	work	work	NOUN
dpc-4097	10	13	.	.	PUNCT
dpc-4097	11	1	all	all	DET
dpc-4097	11	2	authors	author	NOUN
dpc-4097	11	3	have	have	AUX
dpc-4097	11	4	contributed	contribute	VERB
dpc-4097	11	5	significantly	significantly	ADV
dpc-4097	11	6	to	to	ADP
dpc-4097	11	7	this	this	DET
dpc-4097	11	8	publication	publication	NOUN
dpc-4097	11	9	.	.	PUNCT
dpc-4097	12	1	corresponding	correspond	VERB
dpc-4097	12	2	author	author	NOUN
dpc-4097	12	3	:	:	PUNCT
dpc-4097	12	4	mussi	mussi	PROPN
dpc-4097	12	5	martina	martina	PROPN
dpc-4097	12	6	md	md	PROPN
dpc-4097	12	7	,	,	PUNCT
dpc-4097	12	8	department	department	PROPN
dpc-4097	12	9	of	of	ADP
dpc-4097	12	10	medical	medical	ADJ
dpc-4097	12	11	and	and	CCONJ
dpc-4097	12	12	surgical	surgical	ADJ
dpc-4097	12	13	sciences	science	NOUN
dpc-4097	12	14	alma	alma	NOUN
dpc-4097	12	15	mater	mater	PROPN
dpc-4097	12	16	studiorum	studiorum	PROPN
dpc-4097	12	17	university	university	PROPN
dpc-4097	12	18	of	of	ADP
dpc-4097	12	19	bologna	bologna	PROPN
dpc-4097	12	20	,	,	PUNCT
dpc-4097	12	21	via	via	ADP
dpc-4097	12	22	massarenti	massarenti	PROPN
dpc-4097	12	23	,	,	PUNCT
dpc-4097	12	24	1	1	NUM
dpc-4097	12	25	40138	40138	NUM
dpc-4097	12	26	bologna	bologna	NOUN
dpc-4097	12	27	,	,	PUNCT
dpc-4097	12	28	italy	italy	PROPN
dpc-4097	12	29	.	.	PUNCT
dpc-4097	13	1	ph	ph	PROPN
dpc-4097	13	2	:	:	PUNCT
dpc-4097	13	3	+39	+39	PROPN
dpc-4097	13	4	051	051	NUM
dpc-4097	13	5	-	-	SYM
dpc-4097	13	6	2144849	2144849	NUM
dpc-4097	13	7	;	;	PUNCT
dpc-4097	13	8	fax	fax	PROPN
dpc-4097	13	9	+39	+39	PROPN
dpc-4097	13	10	051	051	NUM
dpc-4097	13	11	-	-	SYM
dpc-4097	13	12	2144867	2144867	NUM
dpc-4097	13	13	e	e	NOUN
dpc-4097	13	14	-	-	NOUN
dpc-4097	13	15	mail	mail	NOUN
dpc-4097	13	16	:	:	PUNCT
dpc-4097	14	1	mussi.martina1809@gmail.com	mussi.martina1809@gmail.com	NUM
dpc-4097	14	2	introduction	introduction	NOUN
dpc-4097	14	3	:	:	PUNCT
dpc-4097	14	4	historically	historically	ADV
dpc-4097	14	5	,	,	PUNCT
dpc-4097	14	6	difficult	difficult	ADJ
dpc-4097	14	7	-	-	PUNCT
dpc-4097	14	8	to	to	ADP
dpc-4097	14	9	-	-	PUNCT
dpc-4097	14	10	treat	treat	VERB
dpc-4097	14	11	areas	area	NOUN
dpc-4097	14	12	in	in	ADP
dpc-4097	14	13	psoriasis	psoriasis	NOUN
dpc-4097	14	14	included	include	VERB
dpc-4097	14	15	face	face	NOUN
dpc-4097	14	16	,	,	PUNCT
dpc-4097	14	17	scalp	scalp	NOUN
dpc-4097	14	18	,	,	PUNCT
dpc-4097	14	19	folds	fold	NOUN
dpc-4097	14	20	,	,	PUNCT
dpc-4097	14	21	genitalia	genitalia	NOUN
dpc-4097	14	22	,	,	PUNCT
dpc-4097	14	23	nails	nail	NOUN
dpc-4097	14	24	,	,	PUNCT
dpc-4097	14	25	and	and	CCONJ
dpc-4097	14	26	palmoplantar	palmoplantar	NOUN
dpc-4097	14	27	region	region	NOUN
dpc-4097	14	28	.	.	PUNCT
dpc-4097	15	1	recent	recent	ADJ
dpc-4097	15	2	studies	study	NOUN
dpc-4097	15	3	have	have	AUX
dpc-4097	15	4	found	find	VERB
dpc-4097	15	5	that	that	SCONJ
dpc-4097	15	6	lower	low	ADJ
dpc-4097	15	7	limbs	limb	NOUN
dpc-4097	15	8	behave	behave	VERB
dpc-4097	15	9	like	like	ADP
dpc-4097	15	10	a	a	DET
dpc-4097	15	11	“	"	PUNCT
dpc-4097	15	12	new	new	ADJ
dpc-4097	15	13	”	"	PUNCT
dpc-4097	15	14	difficult	difficult	ADJ
dpc-4097	15	15	-	-	PUNCT
dpc-4097	15	16	to	to	ADP
dpc-4097	15	17	-	-	PUNCT
dpc-4097	15	18	treat	treat	VERB
dpc-4097	15	19	area	area	NOUN
dpc-4097	15	20	as	as	SCONJ
dpc-4097	15	21	they	they	PRON
dpc-4097	15	22	can	can	AUX
dpc-4097	15	23	be	be	AUX
dpc-4097	15	24	the	the	DET
dpc-4097	15	25	only	only	ADJ
dpc-4097	15	26	site	site	NOUN
dpc-4097	15	27	of	of	ADP
dpc-4097	15	28	residual	residual	ADJ
dpc-4097	15	29	disease	disease	NOUN
dpc-4097	15	30	even	even	ADV
dpc-4097	15	31	in	in	ADP
dpc-4097	15	32	patients	patient	NOUN
dpc-4097	15	33	undergoing	undergo	VERB
dpc-4097	15	34	biologic	biologic	ADJ
dpc-4097	15	35	therapies	therapy	NOUN
dpc-4097	15	36	.	.	PUNCT
dpc-4097	16	1	objectives	objective	NOUN
dpc-4097	16	2	:	:	PUNCT
dpc-4097	16	3	we	we	PRON
dpc-4097	16	4	aimed	aim	VERB
dpc-4097	16	5	to	to	PART
dpc-4097	16	6	evaluate	evaluate	VERB
dpc-4097	16	7	whether	whether	SCONJ
dpc-4097	16	8	legs	leg	NOUN
dpc-4097	16	9	had	have	VERB
dpc-4097	16	10	different	different	ADJ
dpc-4097	16	11	response	response	NOUN
dpc-4097	16	12	rates	rate	NOUN
dpc-4097	16	13	and	and	CCONJ
dpc-4097	16	14	response	response	NOUN
dpc-4097	16	15	times	time	NOUN
dpc-4097	16	16	to	to	ADP
dpc-4097	16	17	treatment	treatment	NOUN
dpc-4097	16	18	with	with	ADP
dpc-4097	16	19	a	a	DET
dpc-4097	16	20	new	new	ADJ
dpc-4097	16	21	biologic	biologic	NOUN
dpc-4097	16	22	drug	drug	NOUN
dpc-4097	16	23	,	,	PUNCT
dpc-4097	16	24	risankizumab	risankizumab	NOUN
dpc-4097	16	25	,	,	PUNCT
dpc-4097	16	26	compared	compare	VERB
dpc-4097	16	27	to	to	ADP
dpc-4097	16	28	other	other	ADJ
dpc-4097	16	29	body	body	NOUN
dpc-4097	16	30	sites	site	NOUN
dpc-4097	16	31	.	.	PUNCT
dpc-4097	17	1	abstract	abstract	ADJ
dpc-4097	17	2	2	2	NUM
dpc-4097	17	3	original	original	ADJ
dpc-4097	17	4	article	article	NOUN
dpc-4097	17	5	|	|	ADV
dpc-4097	17	6	dermatol	dermatol	ADJ
dpc-4097	17	7	pract	pract	NOUN
dpc-4097	17	8	concept	concept	NOUN
dpc-4097	17	9	.	.	PUNCT
dpc-4097	18	1	2024;14(3):e2024171	2024;14(3):e2024171	NUM
dpc-4097	18	2	introduction	introduction	NOUN
dpc-4097	18	3	psoriasis	psoriasis	NOUN
dpc-4097	18	4	is	be	AUX
dpc-4097	18	5	a	a	DET
dpc-4097	18	6	chronic	chronic	ADJ
dpc-4097	18	7	inflammatory	inflammatory	ADJ
dpc-4097	18	8	disease	disease	NOUN
dpc-4097	18	9	that	that	PRON
dpc-4097	18	10	can	can	AUX
dpc-4097	18	11	affect	affect	VERB
dpc-4097	18	12	any	any	DET
dpc-4097	18	13	part	part	NOUN
dpc-4097	18	14	of	of	ADP
dpc-4097	18	15	the	the	DET
dpc-4097	18	16	body	body	NOUN
dpc-4097	18	17	[	[	X
dpc-4097	18	18	1	1	NUM
dpc-4097	18	19	]	]	PUNCT
dpc-4097	18	20	.	.	PUNCT
dpc-4097	19	1	some	some	PRON
dpc-4097	19	2	of	of	ADP
dpc-4097	19	3	these	these	PRON
dpc-4097	19	4	are	be	AUX
dpc-4097	19	5	traditionally	traditionally	ADV
dpc-4097	19	6	considered	consider	VERB
dpc-4097	19	7	difficult	difficult	ADJ
dpc-4097	19	8	-	-	PUNCT
dpc-4097	19	9	to	to	ADP
dpc-4097	19	10	-	-	PUNCT
dpc-4097	19	11	treat	treat	NOUN
dpc-4097	19	12	areas	area	NOUN
dpc-4097	19	13	;	;	PUNCT
dpc-4097	19	14	in	in	ADP
dpc-4097	19	15	the	the	DET
dpc-4097	19	16	pre	pre	ADJ
dpc-4097	19	17	-	-	ADJ
dpc-4097	19	18	biological	biological	ADJ
dpc-4097	19	19	therapy	therapy	NOUN
dpc-4097	19	20	era	era	NOUN
dpc-4097	19	21	,	,	PUNCT
dpc-4097	19	22	the	the	DET
dpc-4097	19	23	application	application	NOUN
dpc-4097	19	24	of	of	ADP
dpc-4097	19	25	topical	topical	ADJ
dpc-4097	19	26	products	product	NOUN
dpc-4097	19	27	was	be	AUX
dpc-4097	19	28	extremely	extremely	ADV
dpc-4097	19	29	challenging	challenging	ADJ
dpc-4097	19	30	,	,	PUNCT
dpc-4097	19	31	because	because	SCONJ
dpc-4097	19	32	of	of	ADP
dpc-4097	19	33	the	the	DET
dpc-4097	19	34	delicacy	delicacy	NOUN
dpc-4097	19	35	of	of	ADP
dpc-4097	19	36	some	some	DET
dpc-4097	19	37	areas	area	NOUN
dpc-4097	19	38	,	,	PUNCT
dpc-4097	19	39	such	such	ADJ
dpc-4097	19	40	as	as	ADP
dpc-4097	19	41	genitals	genital	NOUN
dpc-4097	19	42	,	,	PUNCT
dpc-4097	19	43	the	the	DET
dpc-4097	19	44	functionality	functionality	NOUN
dpc-4097	19	45	in	in	ADP
dpc-4097	19	46	everyday	everyday	ADJ
dpc-4097	19	47	life	life	NOUN
dpc-4097	19	48	of	of	ADP
dpc-4097	19	49	other	other	ADJ
dpc-4097	19	50	ones	one	NOUN
dpc-4097	19	51	,	,	PUNCT
dpc-4097	19	52	such	such	ADJ
dpc-4097	19	53	as	as	ADP
dpc-4097	19	54	the	the	DET
dpc-4097	19	55	hands	hand	NOUN
dpc-4097	19	56	and	and	CCONJ
dpc-4097	19	57	feet	foot	NOUN
dpc-4097	19	58	,	,	PUNCT
dpc-4097	19	59	and	and	CCONJ
dpc-4097	19	60	because	because	SCONJ
dpc-4097	19	61	of	of	ADP
dpc-4097	19	62	the	the	DET
dpc-4097	19	63	aesthetic	aesthetic	ADJ
dpc-4097	19	64	impairment	impairment	NOUN
dpc-4097	19	65	,	,	PUNCT
dpc-4097	19	66	such	such	ADJ
dpc-4097	19	67	as	as	ADP
dpc-4097	19	68	the	the	DET
dpc-4097	19	69	face	face	NOUN
dpc-4097	19	70	.	.	PUNCT
dpc-4097	20	1	indeed	indeed	ADV
dpc-4097	20	2	,	,	PUNCT
dpc-4097	20	3	the	the	DET
dpc-4097	20	4	anatomical	anatomical	ADJ
dpc-4097	20	5	sites	site	NOUN
dpc-4097	20	6	historically	historically	ADV
dpc-4097	20	7	considered	consider	VERB
dpc-4097	20	8	as	as	ADP
dpc-4097	20	9	“	"	PUNCT
dpc-4097	20	10	difficult	difficult	ADJ
dpc-4097	20	11	-	-	PUNCT
dpc-4097	20	12	to	to	ADP
dpc-4097	20	13	-	-	PUNCT
dpc-4097	20	14	treat	treat	NOUN
dpc-4097	20	15	”	"	PUNCT
dpc-4097	20	16	list	list	NOUN
dpc-4097	20	17	the	the	DET
dpc-4097	20	18	face	face	NOUN
dpc-4097	20	19	,	,	PUNCT
dpc-4097	20	20	scalp	scalp	NOUN
dpc-4097	20	21	,	,	PUNCT
dpc-4097	20	22	folds	fold	NOUN
dpc-4097	20	23	,	,	PUNCT
dpc-4097	20	24	genitalia	genitalia	NOUN
dpc-4097	20	25	,	,	PUNCT
dpc-4097	20	26	nails	nail	NOUN
dpc-4097	20	27	,	,	PUNCT
dpc-4097	20	28	and	and	CCONJ
dpc-4097	20	29	palmoplantar	palmoplantar	NOUN
dpc-4097	20	30	region	region	NOUN
dpc-4097	21	1	[	[	X
dpc-4097	21	2	2	2	NUM
dpc-4097	21	3	]	]	PUNCT
dpc-4097	21	4	.	.	PUNCT
dpc-4097	22	1	however	however	ADV
dpc-4097	22	2	,	,	PUNCT
dpc-4097	22	3	with	with	ADP
dpc-4097	22	4	the	the	DET
dpc-4097	22	5	revolutionary	revolutionary	ADJ
dpc-4097	22	6	introduction	introduction	NOUN
dpc-4097	22	7	of	of	ADP
dpc-4097	22	8	biotechnological	biotechnological	ADJ
dpc-4097	22	9	therapies	therapy	NOUN
dpc-4097	22	10	,	,	PUNCT
dpc-4097	22	11	complete	complete	ADJ
dpc-4097	22	12	or	or	CCONJ
dpc-4097	22	13	nearly	nearly	ADV
dpc-4097	22	14	complete	complete	ADJ
dpc-4097	22	15	clearance	clearance	NOUN
dpc-4097	22	16	of	of	ADP
dpc-4097	22	17	disease	disease	NOUN
dpc-4097	22	18	has	have	AUX
dpc-4097	22	19	been	be	AUX
dpc-4097	22	20	achieved	achieve	VERB
dpc-4097	22	21	even	even	ADV
dpc-4097	22	22	in	in	ADP
dpc-4097	22	23	the	the	DET
dpc-4097	22	24	these	these	DET
dpc-4097	22	25	sites	site	NOUN
dpc-4097	22	26	[	[	X
dpc-4097	22	27	3	3	NUM
dpc-4097	22	28	]	]	PUNCT
dpc-4097	22	29	.	.	PUNCT
dpc-4097	23	1	nevertheless	nevertheless	ADV
dpc-4097	23	2	,	,	PUNCT
dpc-4097	23	3	what	what	PRON
dpc-4097	23	4	has	have	AUX
dpc-4097	23	5	emerged	emerge	VERB
dpc-4097	23	6	from	from	ADP
dpc-4097	23	7	recent	recent	ADJ
dpc-4097	23	8	studies	study	NOUN
dpc-4097	23	9	is	be	AUX
dpc-4097	23	10	the	the	DET
dpc-4097	23	11	evidence	evidence	NOUN
dpc-4097	23	12	that	that	SCONJ
dpc-4097	23	13	the	the	DET
dpc-4097	23	14	lower	low	ADJ
dpc-4097	23	15	limbs	limb	NOUN
dpc-4097	23	16	also	also	ADV
dpc-4097	23	17	behave	behave	VERB
dpc-4097	23	18	like	like	ADP
dpc-4097	23	19	a	a	DET
dpc-4097	23	20	“	"	PUNCT
dpc-4097	23	21	new	new	ADJ
dpc-4097	23	22	”	"	PUNCT
dpc-4097	23	23	difficult	difficult	ADJ
dpc-4097	23	24	-	-	PUNCT
dpc-4097	23	25	to	to	ADP
dpc-4097	23	26	-	-	PUNCT
dpc-4097	23	27	treat	treat	VERB
dpc-4097	23	28	area	area	NOUN
dpc-4097	23	29	as	as	SCONJ
dpc-4097	23	30	they	they	PRON
dpc-4097	23	31	can	can	AUX
dpc-4097	23	32	be	be	AUX
dpc-4097	23	33	the	the	DET
dpc-4097	23	34	only	only	ADJ
dpc-4097	23	35	site	site	NOUN
dpc-4097	23	36	of	of	ADP
dpc-4097	23	37	residual	residual	ADJ
dpc-4097	23	38	disease	disease	NOUN
dpc-4097	23	39	even	even	ADV
dpc-4097	23	40	in	in	ADP
dpc-4097	23	41	patients	patient	NOUN
dpc-4097	23	42	undergoing	undergo	VERB
dpc-4097	23	43	biologic	biologic	ADJ
dpc-4097	23	44	therapies	therapy	NOUN
dpc-4097	23	45	[	[	X
dpc-4097	23	46	4,5	4,5	NUM
dpc-4097	23	47	]	]	PUNCT
dpc-4097	23	48	.	.	PUNCT
dpc-4097	24	1	it	it	PRON
dpc-4097	24	2	is	be	AUX
dpc-4097	24	3	important	important	ADJ
dpc-4097	24	4	to	to	PART
dpc-4097	24	5	remember	remember	VERB
dpc-4097	24	6	that	that	SCONJ
dpc-4097	24	7	each	each	DET
dpc-4097	24	8	site	site	NOUN
dpc-4097	24	9	of	of	ADP
dpc-4097	24	10	the	the	DET
dpc-4097	24	11	body	body	NOUN
dpc-4097	24	12	involved	involve	VERB
dpc-4097	24	13	has	have	VERB
dpc-4097	24	14	a	a	DET
dpc-4097	24	15	different	different	ADJ
dpc-4097	24	16	impact	impact	NOUN
dpc-4097	24	17	on	on	ADP
dpc-4097	24	18	the	the	DET
dpc-4097	24	19	patient	patient	NOUN
dpc-4097	24	20	’s	’s	PART
dpc-4097	24	21	quality	quality	NOUN
dpc-4097	24	22	of	of	ADP
dpc-4097	24	23	life	life	NOUN
dpc-4097	24	24	;	;	PUNCT
dpc-4097	24	25	understanding	understanding	NOUN
dpc-4097	24	26	which	which	DET
dpc-4097	24	27	ones	one	NOUN
dpc-4097	24	28	are	be	AUX
dpc-4097	24	29	less	less	ADV
dpc-4097	24	30	responsive	responsive	ADJ
dpc-4097	24	31	to	to	ADP
dpc-4097	24	32	treatments	treatment	NOUN
dpc-4097	24	33	and	and	CCONJ
dpc-4097	24	34	what	what	DET
dpc-4097	24	35	consequences	consequence	NOUN
dpc-4097	24	36	they	they	PRON
dpc-4097	24	37	can	can	AUX
dpc-4097	24	38	have	have	VERB
dpc-4097	24	39	in	in	ADP
dpc-4097	24	40	everyday	everyday	ADJ
dpc-4097	24	41	life	life	NOUN
dpc-4097	24	42	can	can	AUX
dpc-4097	24	43	therefore	therefore	ADV
dpc-4097	24	44	be	be	AUX
dpc-4097	24	45	very	very	ADV
dpc-4097	24	46	useful	useful	ADJ
dpc-4097	24	47	to	to	ADP
dpc-4097	24	48	the	the	DET
dpc-4097	24	49	clinicians	clinician	NOUN
dpc-4097	24	50	in	in	ADP
dpc-4097	24	51	guiding	guide	VERB
dpc-4097	24	52	therapeutic	therapeutic	ADJ
dpc-4097	24	53	choices	choice	NOUN
dpc-4097	24	54	and	and	CCONJ
dpc-4097	24	55	providing	provide	VERB
dpc-4097	24	56	adequate	adequate	ADJ
dpc-4097	24	57	patient	patient	ADJ
dpc-4097	24	58	counselling	counselling	NOUN
dpc-4097	24	59	.	.	PUNCT
dpc-4097	25	1	based	base	VERB
dpc-4097	25	2	on	on	ADP
dpc-4097	25	3	the	the	DET
dpc-4097	25	4	recent	recent	ADJ
dpc-4097	25	5	scientific	scientific	ADJ
dpc-4097	25	6	literature	literature	NOUN
dpc-4097	25	7	,	,	PUNCT
dpc-4097	25	8	which	which	PRON
dpc-4097	25	9	has	have	AUX
dpc-4097	25	10	identified	identify	VERB
dpc-4097	25	11	the	the	DET
dpc-4097	25	12	legs	leg	NOUN
dpc-4097	25	13	as	as	ADP
dpc-4097	25	14	a	a	DET
dpc-4097	25	15	new	new	ADJ
dpc-4097	25	16	difficult	difficult	ADJ
dpc-4097	25	17	-	-	PUNCT
dpc-4097	25	18	to	to	ADP
dpc-4097	25	19	-	-	PUNCT
dpc-4097	25	20	treat	treat	NOUN
dpc-4097	25	21	area	area	NOUN
dpc-4097	25	22	,	,	PUNCT
dpc-4097	25	23	the	the	DET
dpc-4097	25	24	aim	aim	NOUN
dpc-4097	25	25	of	of	ADP
dpc-4097	25	26	this	this	DET
dpc-4097	25	27	study	study	NOUN
dpc-4097	25	28	was	be	AUX
dpc-4097	25	29	to	to	PART
dpc-4097	25	30	examine	examine	VERB
dpc-4097	25	31	whether	whether	SCONJ
dpc-4097	25	32	legs	leg	NOUN
dpc-4097	25	33	had	have	VERB
dpc-4097	25	34	different	different	ADJ
dpc-4097	25	35	response	response	NOUN
dpc-4097	25	36	rates	rate	NOUN
dpc-4097	25	37	and	and	CCONJ
dpc-4097	25	38	response	response	NOUN
dpc-4097	25	39	times	time	NOUN
dpc-4097	25	40	to	to	ADP
dpc-4097	25	41	psoriatic	psoriatic	ADJ
dpc-4097	25	42	-	-	PUNCT
dpc-4097	25	43	specific	specific	ADJ
dpc-4097	25	44	treatment	treatment	NOUN
dpc-4097	25	45	compared	compare	VERB
dpc-4097	25	46	to	to	ADP
dpc-4097	25	47	other	other	ADJ
dpc-4097	25	48	body	body	NOUN
dpc-4097	25	49	sites	site	NOUN
dpc-4097	25	50	in	in	ADP
dpc-4097	25	51	a	a	DET
dpc-4097	25	52	group	group	NOUN
dpc-4097	25	53	of	of	ADP
dpc-4097	25	54	psoriatic	psoriatic	ADJ
dpc-4097	25	55	patients	patient	NOUN
dpc-4097	25	56	from	from	ADP
dpc-4097	25	57	different	different	ADJ
dpc-4097	25	58	italian	italian	ADJ
dpc-4097	25	59	centers	center	NOUN
dpc-4097	25	60	who	who	PRON
dpc-4097	25	61	participated	participate	VERB
dpc-4097	25	62	in	in	ADP
dpc-4097	25	63	this	this	DET
dpc-4097	25	64	investigation	investigation	NOUN
dpc-4097	25	65	.	.	PUNCT
dpc-4097	26	1	objective	objective	ADJ
dpc-4097	26	2	some	some	DET
dpc-4097	26	3	data	datum	NOUN
dpc-4097	26	4	have	have	AUX
dpc-4097	26	5	already	already	ADV
dpc-4097	26	6	been	be	AUX
dpc-4097	26	7	reported	report	VERB
dpc-4097	26	8	regarding	regard	VERB
dpc-4097	26	9	the	the	DET
dpc-4097	26	10	use	use	NOUN
dpc-4097	26	11	of	of	ADP
dpc-4097	26	12	biological	biological	ADJ
dpc-4097	26	13	drugs	drug	NOUN
dpc-4097	26	14	in	in	ADP
dpc-4097	26	15	psoriatic	psoriatic	ADJ
dpc-4097	26	16	patients	patient	NOUN
dpc-4097	26	17	with	with	ADP
dpc-4097	26	18	leg	leg	NOUN
dpc-4097	26	19	involvement	involvement	NOUN
dpc-4097	26	20	[	[	X
dpc-4097	26	21	6	6	NUM
dpc-4097	26	22	]	]	PUNCT
dpc-4097	26	23	.	.	PUNCT
dpc-4097	27	1	based	base	VERB
dpc-4097	27	2	on	on	ADP
dpc-4097	27	3	this	this	DET
dpc-4097	27	4	consideration	consideration	NOUN
dpc-4097	27	5	and	and	CCONJ
dpc-4097	27	6	on	on	ADP
dpc-4097	27	7	the	the	DET
dpc-4097	27	8	already	already	ADV
dpc-4097	27	9	proven	prove	VERB
dpc-4097	27	10	efficacy	efficacy	NOUN
dpc-4097	27	11	of	of	ADP
dpc-4097	27	12	this	this	DET
dpc-4097	27	13	recent	recent	ADJ
dpc-4097	27	14	,	,	PUNCT
dpc-4097	27	15	promising	promising	ADJ
dpc-4097	27	16	drug	drug	NOUN
dpc-4097	27	17	,	,	PUNCT
dpc-4097	27	18	we	we	PRON
dpc-4097	27	19	retrospectively	retrospectively	ADV
dpc-4097	27	20	reviewed	review	VERB
dpc-4097	27	21	psoriatic	psoriatic	ADJ
dpc-4097	27	22	patients	patient	NOUN
dpc-4097	27	23	treated	treat	VERB
dpc-4097	27	24	with	with	ADP
dpc-4097	27	25	risankizumab	risankizumab	NOUN
dpc-4097	27	26	to	to	PART
dpc-4097	27	27	evaluate	evaluate	VERB
dpc-4097	27	28	the	the	DET
dpc-4097	27	29	site	site	NOUN
dpc-4097	27	30	-	-	PUNCT
dpc-4097	27	31	specific	specific	ADJ
dpc-4097	27	32	response	response	NOUN
dpc-4097	27	33	.	.	PUNCT
dpc-4097	28	1	methods	method	NOUN
dpc-4097	28	2	we	we	PRON
dpc-4097	28	3	conducted	conduct	VERB
dpc-4097	28	4	a	a	DET
dpc-4097	28	5	real	real	ADJ
dpc-4097	28	6	-	-	PUNCT
dpc-4097	28	7	life	life	NOUN
dpc-4097	28	8	,	,	PUNCT
dpc-4097	28	9	observational	observational	ADJ
dpc-4097	28	10	,	,	PUNCT
dpc-4097	28	11	retrospective	retrospective	ADJ
dpc-4097	28	12	,	,	PUNCT
dpc-4097	28	13	multicenter	multicenter	ADJ
dpc-4097	28	14	study	study	NOUN
dpc-4097	28	15	,	,	PUNCT
dpc-4097	28	16	with	with	SCONJ
dpc-4097	28	17	nine	nine	NUM
dpc-4097	28	18	centers	center	NOUN
dpc-4097	28	19	in	in	ADP
dpc-4097	28	20	emilia	emilia	PROPN
dpc-4097	28	21	-	-	PUNCT
dpc-4097	28	22	romagna	romagna	PROPN
dpc-4097	28	23	(	(	PUNCT
dpc-4097	28	24	italy	italy	PROPN
dpc-4097	28	25	)	)	PUNCT
dpc-4097	28	26	specialized	specialize	VERB
dpc-4097	28	27	in	in	ADP
dpc-4097	28	28	the	the	DET
dpc-4097	28	29	treatment	treatment	NOUN
dpc-4097	28	30	of	of	ADP
dpc-4097	28	31	psoriasis	psoriasis	NOUN
dpc-4097	28	32	participating	participate	VERB
dpc-4097	28	33	in	in	ADP
dpc-4097	28	34	the	the	DET
dpc-4097	28	35	investigation	investigation	NOUN
dpc-4097	28	36	.	.	PUNCT
dpc-4097	29	1	patients	patient	NOUN
dpc-4097	29	2	affected	affect	VERB
dpc-4097	29	3	by	by	ADP
dpc-4097	29	4	moderate	moderate	ADJ
dpc-4097	29	5	to	to	ADP
dpc-4097	29	6	severe	severe	ADJ
dpc-4097	29	7	psoriasis	psoriasis	NOUN
dpc-4097	29	8	with	with	ADP
dpc-4097	29	9	involvement	involvement	NOUN
dpc-4097	29	10	of	of	ADP
dpc-4097	29	11	the	the	DET
dpc-4097	29	12	legs	leg	NOUN
dpc-4097	29	13	and	and	CCONJ
dpc-4097	29	14	undergoing	undergo	VERB
dpc-4097	29	15	biological	biological	ADJ
dpc-4097	29	16	therapy	therapy	NOUN
dpc-4097	29	17	with	with	ADP
dpc-4097	29	18	risankizumab	risankizumab	NOUN
dpc-4097	29	19	for	for	ADP
dpc-4097	29	20	more	more	ADJ
dpc-4097	29	21	than	than	ADP
dpc-4097	29	22	16	16	NUM
dpc-4097	29	23	weeks	week	NOUN
dpc-4097	29	24	were	be	AUX
dpc-4097	29	25	selected	select	VERB
dpc-4097	29	26	.	.	PUNCT
dpc-4097	30	1	of	of	ADP
dpc-4097	30	2	each	each	DET
dpc-4097	30	3	patient	patient	NOUN
dpc-4097	30	4	,	,	PUNCT
dpc-4097	30	5	demographic	demographic	ADJ
dpc-4097	30	6	data	datum	NOUN
dpc-4097	30	7	,	,	PUNCT
dpc-4097	30	8	the	the	DET
dpc-4097	30	9	duration	duration	NOUN
dpc-4097	30	10	and	and	CCONJ
dpc-4097	30	11	type	type	NOUN
dpc-4097	30	12	of	of	ADP
dpc-4097	30	13	psoriasis	psoriasis	NOUN
dpc-4097	30	14	,	,	PUNCT
dpc-4097	30	15	the	the	DET
dpc-4097	30	16	diagnosis	diagnosis	NOUN
dpc-4097	30	17	of	of	ADP
dpc-4097	30	18	psoriatic	psoriatic	ADJ
dpc-4097	30	19	arthritis	arthritis	NOUN
dpc-4097	30	20	,	,	PUNCT
dpc-4097	30	21	and	and	CCONJ
dpc-4097	30	22	the	the	DET
dpc-4097	30	23	anatomical	anatomical	ADJ
dpc-4097	30	24	site	site	NOUN
dpc-4097	30	25	of	of	ADP
dpc-4097	30	26	disease	disease	NOUN
dpc-4097	30	27	involvement	involvement	NOUN
dpc-4097	30	28	were	be	AUX
dpc-4097	30	29	evaluated	evaluate	VERB
dpc-4097	30	30	.	.	PUNCT
dpc-4097	31	1	moreover	moreover	ADV
dpc-4097	31	2	,	,	PUNCT
dpc-4097	31	3	all	all	DET
dpc-4097	31	4	previous	previous	ADJ
dpc-4097	31	5	traditional	traditional	ADJ
dpc-4097	31	6	and	and	CCONJ
dpc-4097	31	7	biological	biological	ADJ
dpc-4097	31	8	therapies	therapy	NOUN
dpc-4097	31	9	,	,	PUNCT
dpc-4097	31	10	the	the	DET
dpc-4097	31	11	duration	duration	NOUN
dpc-4097	31	12	of	of	ADP
dpc-4097	31	13	each	each	DET
dpc-4097	31	14	treatment	treatment	NOUN
dpc-4097	31	15	,	,	PUNCT
dpc-4097	31	16	and	and	CCONJ
dpc-4097	31	17	concomitant	concomitant	ADJ
dpc-4097	31	18	medications	medication	NOUN
dpc-4097	31	19	were	be	AUX
dpc-4097	31	20	collected	collect	VERB
dpc-4097	31	21	.	.	PUNCT
dpc-4097	32	1	the	the	DET
dpc-4097	32	2	psoriasis	psoriasis	NOUN
dpc-4097	32	3	area	area	NOUN
dpc-4097	32	4	severity	severity	NOUN
dpc-4097	32	5	index	index	NOUN
dpc-4097	32	6	(	(	PUNCT
dpc-4097	32	7	pasi	pasi	NOUN
dpc-4097	32	8	)	)	PUNCT
dpc-4097	32	9	and	and	CCONJ
dpc-4097	32	10	leg	leg	NOUN
dpc-4097	32	11	-	-	PUNCT
dpc-4097	32	12	pasi	pasi	NOUN
dpc-4097	32	13	were	be	AUX
dpc-4097	32	14	collected	collect	VERB
dpc-4097	32	15	at	at	ADP
dpc-4097	32	16	t0	t0	PROPN
dpc-4097	32	17	and	and	CCONJ
dpc-4097	32	18	at	at	ADP
dpc-4097	32	19	weeks	week	NOUN
dpc-4097	32	20	16	16	NUM
dpc-4097	32	21	,	,	PUNCT
dpc-4097	32	22	28	28	NUM
dpc-4097	32	23	,	,	PUNCT
dpc-4097	32	24	40	40	NUM
dpc-4097	32	25	,	,	PUNCT
dpc-4097	32	26	52	52	NUM
dpc-4097	32	27	,	,	PUNCT
dpc-4097	32	28	64	64	NUM
dpc-4097	32	29	,	,	PUNCT
dpc-4097	32	30	and	and	CCONJ
dpc-4097	32	31	76	76	NUM
dpc-4097	32	32	,	,	PUNCT
dpc-4097	32	33	if	if	SCONJ
dpc-4097	32	34	available	available	ADJ
dpc-4097	32	35	,	,	PUNCT
dpc-4097	32	36	for	for	ADP
dpc-4097	32	37	each	each	DET
dpc-4097	32	38	patient	patient	NOUN
dpc-4097	32	39	included	include	VERB
dpc-4097	32	40	in	in	ADP
dpc-4097	32	41	the	the	DET
dpc-4097	32	42	study	study	NOUN
dpc-4097	32	43	.	.	PUNCT
dpc-4097	33	1	the	the	DET
dpc-4097	33	2	body	body	NOUN
dpc-4097	33	3	area	area	NOUN
dpc-4097	33	4	corresponding	correspond	VERB
dpc-4097	33	5	to	to	ADP
dpc-4097	33	6	the	the	DET
dpc-4097	33	7	leg	leg	NOUN
dpc-4097	33	8	was	be	AUX
dpc-4097	33	9	defined	define	VERB
dpc-4097	33	10	as	as	ADP
dpc-4097	33	11	the	the	DET
dpc-4097	33	12	skin	skin	NOUN
dpc-4097	33	13	below	below	ADP
dpc-4097	33	14	the	the	DET
dpc-4097	33	15	knee	knee	NOUN
dpc-4097	33	16	,	,	PUNCT
dpc-4097	33	17	except	except	SCONJ
dpc-4097	33	18	for	for	ADP
dpc-4097	33	19	the	the	DET
dpc-4097	33	20	sole	sole	NOUN
dpc-4097	33	21	and	and	CCONJ
dpc-4097	33	22	the	the	DET
dpc-4097	33	23	toenails	toenail	NOUN
dpc-4097	33	24	.	.	PUNCT
dpc-4097	34	1	according	accord	VERB
dpc-4097	34	2	to	to	ADP
dpc-4097	34	3	lund	lund	PROPN
dpc-4097	34	4	and	and	CCONJ
dpc-4097	34	5	browder	browder	NOUN
dpc-4097	34	6	estimation	estimation	NOUN
dpc-4097	34	7	method	method	NOUN
dpc-4097	34	8	[	[	X
dpc-4097	34	9	7	7	NUM
dpc-4097	34	10	]	]	PUNCT
dpc-4097	34	11	,	,	PUNCT
dpc-4097	34	12	the	the	DET
dpc-4097	34	13	aforementioned	aforementioned	ADJ
dpc-4097	34	14	body	body	NOUN
dpc-4097	34	15	surface	surface	NOUN
dpc-4097	34	16	corresponds	correspond	VERB
dpc-4097	34	17	to	to	ADP
dpc-4097	34	18	17.5	17.5	NUM
dpc-4097	34	19	%	%	NOUN
dpc-4097	34	20	of	of	ADP
dpc-4097	34	21	the	the	DET
dpc-4097	34	22	total	total	ADJ
dpc-4097	34	23	body	body	NOUN
dpc-4097	34	24	surface	surface	NOUN
dpc-4097	34	25	area	area	NOUN
dpc-4097	34	26	.	.	PUNCT
dpc-4097	35	1	therefore	therefore	ADV
dpc-4097	35	2	,	,	PUNCT
dpc-4097	35	3	leg	leg	NOUN
dpc-4097	35	4	-	-	PUNCT
dpc-4097	35	5	pasi	pasi	NOUN
dpc-4097	35	6	was	be	AUX
dpc-4097	35	7	obtained	obtain	VERB
dpc-4097	35	8	by	by	ADP
dpc-4097	35	9	considering	consider	VERB
dpc-4097	35	10	the	the	DET
dpc-4097	35	11	degree	degree	NOUN
dpc-4097	35	12	of	of	ADP
dpc-4097	35	13	redness	redness	NOUN
dpc-4097	35	14	(	(	PUNCT
dpc-4097	35	15	r	r	NOUN
dpc-4097	35	16	)	)	PUNCT
dpc-4097	35	17	,	,	PUNCT
dpc-4097	35	18	scaling	scale	VERB
dpc-4097	35	19	(	(	PUNCT
dpc-4097	35	20	s	s	NOUN
dpc-4097	35	21	)	)	PUNCT
dpc-4097	35	22	,	,	PUNCT
dpc-4097	35	23	and	and	CCONJ
dpc-4097	35	24	thickness	thickness	NOUN
dpc-4097	35	25	(	(	PUNCT
dpc-4097	35	26	t	t	NOUN
dpc-4097	35	27	)	)	PUNCT
dpc-4097	35	28	of	of	ADP
dpc-4097	35	29	the	the	DET
dpc-4097	35	30	leg	leg	NOUN
dpc-4097	35	31	area	area	NOUN
dpc-4097	35	32	,	,	PUNCT
dpc-4097	35	33	multiplied	multiply	VERB
dpc-4097	35	34	by	by	ADP
dpc-4097	35	35	the	the	DET
dpc-4097	35	36	area	area	NOUN
dpc-4097	35	37	estimation	estimation	NOUN
dpc-4097	35	38	coefficient	coefficient	NOUN
dpc-4097	35	39	(	(	PUNCT
dpc-4097	35	40	al	al	PROPN
dpc-4097	35	41	)	)	PUNCT
dpc-4097	35	42	and	and	CCONJ
dpc-4097	35	43	by	by	ADP
dpc-4097	35	44	the	the	DET
dpc-4097	35	45	0.175	0.175	NUM
dpc-4097	35	46	coefficient	coefficient	NOUN
dpc-4097	35	47	,	,	PUNCT
dpc-4097	35	48	in	in	ADP
dpc-4097	35	49	accordance	accordance	NOUN
dpc-4097	35	50	with	with	ADP
dpc-4097	35	51	the	the	DET
dpc-4097	35	52	original	original	ADJ
dpc-4097	35	53	pasi	pasi	NOUN
dpc-4097	35	54	definition	definition	NOUN
dpc-4097	35	55	[	[	X
dpc-4097	35	56	8	8	NUM
dpc-4097	35	57	]	]	PUNCT
dpc-4097	35	58	.	.	PUNCT
dpc-4097	36	1	all	all	DET
dpc-4097	36	2	the	the	DET
dpc-4097	36	3	data	datum	NOUN
dpc-4097	36	4	were	be	AUX
dpc-4097	36	5	extracted	extract	VERB
dpc-4097	36	6	from	from	ADP
dpc-4097	36	7	the	the	DET
dpc-4097	36	8	patient	patient	NOUN
dpc-4097	36	9	records	record	NOUN
dpc-4097	36	10	of	of	ADP
dpc-4097	36	11	each	each	DET
dpc-4097	36	12	participating	participate	VERB
dpc-4097	36	13	hospital	hospital	NOUN
dpc-4097	36	14	.	.	PUNCT
dpc-4097	37	1	statistical	statistical	ADJ
dpc-4097	37	2	descriptive	descriptive	ADJ
dpc-4097	37	3	analysis	analysis	NOUN
dpc-4097	37	4	was	be	AUX
dpc-4097	37	5	then	then	ADV
dpc-4097	37	6	performed	perform	VERB
dpc-4097	37	7	using	use	VERB
dpc-4097	37	8	student	student	NOUN
dpc-4097	37	9	t	t	PROPN
dpc-4097	37	10	-	-	PUNCT
dpc-4097	37	11	test	test	NOUN
dpc-4097	37	12	in	in	ADP
dpc-4097	37	13	order	order	NOUN
dpc-4097	37	14	to	to	PART
dpc-4097	37	15	compare	compare	VERB
dpc-4097	37	16	pasi	pasi	NOUN
dpc-4097	37	17	and	and	CCONJ
dpc-4097	37	18	leg	leg	NOUN
dpc-4097	37	19	-	-	PUNCT
dpc-4097	37	20	pasi	pasi	NOUN
dpc-4097	37	21	improvements	improvement	NOUN
dpc-4097	37	22	at	at	ADP
dpc-4097	37	23	each	each	DET
dpc-4097	37	24	time	time	NOUN
dpc-4097	37	25	point	point	NOUN
dpc-4097	37	26	.	.	PUNCT
dpc-4097	38	1	linear	linear	ADJ
dpc-4097	38	2	regression	regression	NOUN
dpc-4097	38	3	analysis	analysis	NOUN
dpc-4097	38	4	and	and	CCONJ
dpc-4097	38	5	a	a	DET
dpc-4097	38	6	non	non	ADJ
dpc-4097	38	7	-	-	ADJ
dpc-4097	38	8	linear	linear	ADJ
dpc-4097	38	9	regression	regression	NOUN
dpc-4097	38	10	model	model	NOUN
dpc-4097	38	11	(	(	PUNCT
dpc-4097	38	12	cubic	cubic	ADJ
dpc-4097	38	13	polynomial	polynomial	ADJ
dpc-4097	38	14	)	)	PUNCT
dpc-4097	38	15	were	be	AUX
dpc-4097	38	16	also	also	ADV
dpc-4097	38	17	calculated	calculate	VERB
dpc-4097	38	18	to	to	PART
dpc-4097	38	19	analyze	analyze	VERB
dpc-4097	38	20	the	the	DET
dpc-4097	38	21	trend	trend	NOUN
dpc-4097	38	22	of	of	ADP
dpc-4097	38	23	the	the	DET
dpc-4097	38	24	methods	method	NOUN
dpc-4097	38	25	:	:	PUNCT
dpc-4097	38	26	we	we	PRON
dpc-4097	38	27	conducted	conduct	VERB
dpc-4097	38	28	a	a	DET
dpc-4097	38	29	real	real	ADJ
dpc-4097	38	30	-	-	PUNCT
dpc-4097	38	31	life	life	NOUN
dpc-4097	38	32	,	,	PUNCT
dpc-4097	38	33	observational	observational	ADJ
dpc-4097	38	34	,	,	PUNCT
dpc-4097	38	35	retrospective	retrospective	ADJ
dpc-4097	38	36	,	,	PUNCT
dpc-4097	38	37	multicenter	multicenter	ADJ
dpc-4097	38	38	study	study	NOUN
dpc-4097	38	39	including	include	VERB
dpc-4097	38	40	patients	patient	NOUN
dpc-4097	38	41	affected	affect	VERB
dpc-4097	38	42	by	by	ADP
dpc-4097	38	43	moderate	moderate	ADJ
dpc-4097	38	44	-	-	PUNCT
dpc-4097	38	45	to	to	ADP
dpc-4097	38	46	-	-	PUNCT
dpc-4097	38	47	severe	severe	ADJ
dpc-4097	38	48	psoriasis	psoriasis	NOUN
dpc-4097	38	49	with	with	ADP
dpc-4097	38	50	leg	leg	NOUN
dpc-4097	38	51	involvement	involvement	NOUN
dpc-4097	38	52	and	and	CCONJ
dpc-4097	38	53	undergoing	undergo	VERB
dpc-4097	38	54	biological	biological	ADJ
dpc-4097	38	55	therapy	therapy	NOUN
dpc-4097	38	56	with	with	ADP
dpc-4097	38	57	risankizumab	risankizumab	NOUN
dpc-4097	38	58	for	for	ADP
dpc-4097	38	59	more	more	ADJ
dpc-4097	38	60	than	than	ADP
dpc-4097	38	61	16	16	NUM
dpc-4097	38	62	weeks	week	NOUN
dpc-4097	38	63	.	.	PUNCT
dpc-4097	39	1	the	the	DET
dpc-4097	39	2	psoriasis	psoriasis	NOUN
dpc-4097	39	3	area	area	NOUN
dpc-4097	39	4	severity	severity	NOUN
dpc-4097	39	5	index	index	NOUN
dpc-4097	39	6	(	(	PUNCT
dpc-4097	39	7	pasi	pasi	NOUN
dpc-4097	39	8	)	)	PUNCT
dpc-4097	39	9	and	and	CCONJ
dpc-4097	39	10	leg	leg	NOUN
dpc-4097	39	11	-	-	PUNCT
dpc-4097	39	12	pasi	pasi	NOUN
dpc-4097	39	13	were	be	AUX
dpc-4097	39	14	collected	collect	VERB
dpc-4097	39	15	at	at	ADP
dpc-4097	39	16	t0	t0	PROPN
dpc-4097	39	17	and	and	CCONJ
dpc-4097	39	18	at	at	ADP
dpc-4097	39	19	weeks	week	NOUN
dpc-4097	39	20	16	16	NUM
dpc-4097	39	21	,	,	PUNCT
dpc-4097	39	22	28	28	NUM
dpc-4097	39	23	,	,	PUNCT
dpc-4097	39	24	40	40	NUM
dpc-4097	39	25	,	,	PUNCT
dpc-4097	39	26	52	52	NUM
dpc-4097	39	27	,	,	PUNCT
dpc-4097	39	28	64	64	NUM
dpc-4097	39	29	,	,	PUNCT
dpc-4097	39	30	and	and	CCONJ
dpc-4097	39	31	76	76	NUM
dpc-4097	39	32	.	.	PUNCT
dpc-4097	40	1	statistical	statistical	ADJ
dpc-4097	40	2	analysis	analysis	NOUN
dpc-4097	40	3	using	use	VERB
dpc-4097	40	4	student	student	NOUN
dpc-4097	40	5	’s	’s	PART
dpc-4097	40	6	t	t	PROPN
dpc-4097	40	7	test	test	NOUN
dpc-4097	40	8	and	and	CCONJ
dpc-4097	40	9	linear	linear	PROPN
dpc-4097	40	10	regression	regression	NOUN
dpc-4097	40	11	analysis	analysis	NOUN
dpc-4097	40	12	were	be	AUX
dpc-4097	40	13	performed	perform	VERB
dpc-4097	40	14	.	.	PUNCT
dpc-4097	41	1	results	result	NOUN
dpc-4097	41	2	:	:	PUNCT
dpc-4097	41	3	a	a	DET
dpc-4097	41	4	total	total	NOUN
dpc-4097	41	5	of	of	ADP
dpc-4097	41	6	124	124	NUM
dpc-4097	41	7	patients	patient	NOUN
dpc-4097	41	8	were	be	AUX
dpc-4097	41	9	included	include	VERB
dpc-4097	41	10	.	.	PUNCT
dpc-4097	42	1	the	the	DET
dpc-4097	42	2	difference	difference	NOUN
dpc-4097	42	3	between	between	ADP
dpc-4097	42	4	the	the	DET
dpc-4097	42	5	improvement	improvement	NOUN
dpc-4097	42	6	percentage	percentage	NOUN
dpc-4097	42	7	compared	compare	VERB
dpc-4097	42	8	to	to	ADP
dpc-4097	42	9	baseline	baseline	VERB
dpc-4097	42	10	was	be	AUX
dpc-4097	42	11	statistically	statistically	ADV
dpc-4097	42	12	significant	significant	ADJ
dpc-4097	42	13	at	at	ADP
dpc-4097	42	14	weeks	week	NOUN
dpc-4097	42	15	16	16	NUM
dpc-4097	42	16	and	and	CCONJ
dpc-4097	42	17	28	28	NUM
dpc-4097	42	18	,	,	PUNCT
dpc-4097	42	19	demonstrating	demonstrate	VERB
dpc-4097	42	20	that	that	SCONJ
dpc-4097	42	21	leg	leg	NOUN
dpc-4097	42	22	-	-	PUNCT
dpc-4097	42	23	pasi	pasi	NOUN
dpc-4097	42	24	improved	improve	VERB
dpc-4097	42	25	less	less	ADJ
dpc-4097	42	26	than	than	ADP
dpc-4097	42	27	pasi	pasi	NOUN
dpc-4097	42	28	.	.	PUNCT
dpc-4097	43	1	from	from	ADP
dpc-4097	43	2	the	the	DET
dpc-4097	43	3	linear	linear	ADJ
dpc-4097	43	4	regression	regression	NOUN
dpc-4097	43	5	it	it	PRON
dpc-4097	43	6	was	be	AUX
dpc-4097	43	7	deduced	deduce	VERB
dpc-4097	43	8	that	that	SCONJ
dpc-4097	43	9	the	the	DET
dpc-4097	43	10	slope	slope	NOUN
dpc-4097	43	11	is	be	AUX
dpc-4097	43	12	statistically	statistically	ADV
dpc-4097	43	13	less	less	ADV
dpc-4097	43	14	steep	steep	ADJ
dpc-4097	43	15	for	for	ADP
dpc-4097	43	16	leg	leg	NOUN
dpc-4097	43	17	-	-	PUNCT
dpc-4097	43	18	pasi	pasi	NOUN
dpc-4097	43	19	than	than	ADP
dpc-4097	43	20	for	for	ADP
dpc-4097	43	21	overall	overall	ADJ
dpc-4097	43	22	pasi	pasi	NOUN
dpc-4097	43	23	,	,	PUNCT
dpc-4097	43	24	confirming	confirm	VERB
dpc-4097	43	25	that	that	SCONJ
dpc-4097	43	26	this	this	DET
dpc-4097	43	27	site	site	NOUN
dpc-4097	43	28	responds	respond	VERB
dpc-4097	43	29	more	more	ADV
dpc-4097	43	30	slowly	slowly	ADV
dpc-4097	43	31	to	to	ADP
dpc-4097	43	32	the	the	DET
dpc-4097	43	33	therapy	therapy	NOUN
dpc-4097	43	34	.	.	PUNCT
dpc-4097	44	1	conclusions	conclusion	NOUN
dpc-4097	44	2	:	:	PUNCT
dpc-4097	44	3	leg	leg	NOUN
dpc-4097	44	4	response	response	NOUN
dpc-4097	44	5	to	to	ADP
dpc-4097	44	6	risankizumab	risankizumab	NOUN
dpc-4097	44	7	appears	appear	VERB
dpc-4097	44	8	to	to	PART
dpc-4097	44	9	differ	differ	VERB
dpc-4097	44	10	significantly	significantly	ADV
dpc-4097	44	11	from	from	ADP
dpc-4097	44	12	other	other	ADJ
dpc-4097	44	13	body	body	NOUN
dpc-4097	44	14	sites	site	NOUN
dpc-4097	44	15	in	in	ADP
dpc-4097	44	16	the	the	DET
dpc-4097	44	17	first	first	ADJ
dpc-4097	44	18	weeks	week	NOUN
dpc-4097	44	19	of	of	ADP
dpc-4097	44	20	treatment	treatment	NOUN
dpc-4097	44	21	,	,	PUNCT
dpc-4097	44	22	even	even	ADV
dpc-4097	44	23	if	if	SCONJ
dpc-4097	44	24	after	after	ADP
dpc-4097	44	25	28	28	NUM
dpc-4097	44	26	weeks	week	NOUN
dpc-4097	44	27	,	,	PUNCT
dpc-4097	44	28	statistical	statistical	ADJ
dpc-4097	44	29	significance	significance	NOUN
dpc-4097	44	30	is	be	AUX
dpc-4097	44	31	lost	lose	VERB
dpc-4097	44	32	.	.	PUNCT
dpc-4097	45	1	our	our	PRON
dpc-4097	45	2	preliminary	preliminary	ADJ
dpc-4097	45	3	finding	finding	NOUN
dpc-4097	45	4	suggests	suggest	VERB
dpc-4097	45	5	that	that	SCONJ
dpc-4097	45	6	risankizumab	risankizumab	NOUN
dpc-4097	45	7	can	can	AUX
dpc-4097	45	8	be	be	AUX
dpc-4097	45	9	considered	consider	VERB
dpc-4097	45	10	an	an	DET
dpc-4097	45	11	effective	effective	ADJ
dpc-4097	45	12	treatment	treatment	NOUN
dpc-4097	45	13	for	for	ADP
dpc-4097	45	14	leg	leg	NOUN
dpc-4097	45	15	psoriasis	psoriasis	NOUN
dpc-4097	45	16	but	but	CCONJ
dpc-4097	45	17	with	with	ADP
dpc-4097	45	18	longer	long	ADJ
dpc-4097	45	19	response	response	NOUN
dpc-4097	45	20	times	time	NOUN
dpc-4097	45	21	than	than	ADP
dpc-4097	45	22	other	other	ADJ
dpc-4097	45	23	areas	area	NOUN
dpc-4097	45	24	,	,	PUNCT
dpc-4097	45	25	demonstrating	demonstrate	VERB
dpc-4097	45	26	the	the	DET
dpc-4097	45	27	relative	relative	ADJ
dpc-4097	45	28	nature	nature	NOUN
dpc-4097	45	29	of	of	ADP
dpc-4097	45	30	resistance	resistance	NOUN
dpc-4097	45	31	to	to	ADP
dpc-4097	45	32	treatment	treatment	NOUN
dpc-4097	45	33	of	of	ADP
dpc-4097	45	34	this	this	DET
dpc-4097	45	35	district	district	NOUN
dpc-4097	45	36	.	.	PUNCT
dpc-4097	46	1	original	original	ADJ
dpc-4097	46	2	article	article	NOUN
dpc-4097	46	3	|	|	ADV
dpc-4097	46	4	dermatol	dermatol	ADJ
dpc-4097	46	5	pract	pract	NOUN
dpc-4097	46	6	concept	concept	NOUN
dpc-4097	46	7	.	.	PUNCT
dpc-4097	47	1	2024;14(3):e2024171	2024;14(3):e2024171	NUM
dpc-4097	47	2	3	3	NUM
dpc-4097	47	3	pasi	pasi	NOUN
dpc-4097	47	4	and	and	CCONJ
dpc-4097	47	5	leg	leg	NOUN
dpc-4097	47	6	-	-	PUNCT
dpc-4097	47	7	pasi	pasi	NOUN
dpc-4097	47	8	over	over	ADP
dpc-4097	47	9	time	time	NOUN
dpc-4097	47	10	.	.	PUNCT
dpc-4097	48	1	a	a	DET
dpc-4097	48	2	p	p	NOUN
dpc-4097	48	3	value	value	NOUN
dpc-4097	48	4	less	less	ADJ
dpc-4097	48	5	than	than	ADP
dpc-4097	48	6	0.05	0.05	NUM
dpc-4097	48	7	was	be	AUX
dpc-4097	48	8	considered	consider	VERB
dpc-4097	48	9	significant	significant	ADJ
dpc-4097	48	10	.	.	PUNCT
dpc-4097	49	1	statistical	statistical	ADJ
dpc-4097	49	2	analysis	analysis	NOUN
dpc-4097	49	3	was	be	AUX
dpc-4097	49	4	performed	perform	VERB
dpc-4097	49	5	using	use	VERB
dpc-4097	49	6	prism	prism	NOUN
dpc-4097	49	7	software	software	NOUN
dpc-4097	49	8	(	(	PUNCT
dpc-4097	49	9	prism	prism	NOUN
dpc-4097	49	10	6.0	6.0	NUM
dpc-4097	49	11	,	,	PUNCT
dpc-4097	49	12	graphpad	graphpad	NOUN
dpc-4097	49	13	software	software	PROPN
dpc-4097	49	14	,	,	PUNCT
dpc-4097	49	15	inc	inc	PROPN
dpc-4097	49	16	.	.	PROPN
dpc-4097	49	17	,	,	PUNCT
dpc-4097	49	18	ca	ca	NOUN
dpc-4097	49	19	)	)	PUNCT
dpc-4097	49	20	.	.	PUNCT
dpc-4097	50	1	results	result	NOUN
dpc-4097	50	2	we	we	PRON
dpc-4097	50	3	included	include	VERB
dpc-4097	50	4	a	a	DET
dpc-4097	50	5	total	total	NOUN
dpc-4097	50	6	of	of	ADP
dpc-4097	50	7	124	124	NUM
dpc-4097	50	8	patients	patient	NOUN
dpc-4097	50	9	,	,	PUNCT
dpc-4097	50	10	74	74	NUM
dpc-4097	50	11	of	of	ADP
dpc-4097	50	12	whom	whom	PRON
dpc-4097	50	13	were	be	AUX
dpc-4097	50	14	male	male	ADJ
dpc-4097	50	15	,	,	PUNCT
dpc-4097	50	16	with	with	ADP
dpc-4097	50	17	a	a	DET
dpc-4097	50	18	mean	mean	ADJ
dpc-4097	50	19	age	age	NOUN
dpc-4097	50	20	of	of	ADP
dpc-4097	50	21	55	55	NUM
dpc-4097	50	22	years	year	NOUN
dpc-4097	50	23	old	old	ADJ
dpc-4097	50	24	,	,	PUNCT
dpc-4097	50	25	a	a	DET
dpc-4097	50	26	mean	mean	ADJ
dpc-4097	50	27	bmi	bmi	NOUN
dpc-4097	50	28	of	of	ADP
dpc-4097	50	29	28.6	28.6	NUM
dpc-4097	50	30	,	,	PUNCT
dpc-4097	50	31	and	and	CCONJ
dpc-4097	50	32	a	a	DET
dpc-4097	50	33	mean	mean	ADJ
dpc-4097	50	34	disease	disease	NOUN
dpc-4097	50	35	duration	duration	NOUN
dpc-4097	50	36	of	of	ADP
dpc-4097	50	37	21.27	21.27	NUM
dpc-4097	50	38	years	year	NOUN
dpc-4097	50	39	.	.	PUNCT
dpc-4097	51	1	regarding	regard	VERB
dpc-4097	51	2	the	the	DET
dpc-4097	51	3	type	type	NOUN
dpc-4097	51	4	of	of	ADP
dpc-4097	51	5	psoriasis	psoriasis	NOUN
dpc-4097	51	6	,	,	PUNCT
dpc-4097	51	7	120	120	NUM
dpc-4097	51	8	(	(	PUNCT
dpc-4097	51	9	96.7	96.7	NUM
dpc-4097	51	10	%	%	NOUN
dpc-4097	51	11	)	)	PUNCT
dpc-4097	51	12	patients	patient	NOUN
dpc-4097	51	13	presented	present	VERB
dpc-4097	51	14	a	a	DET
dpc-4097	51	15	vulgar	vulgar	ADJ
dpc-4097	51	16	form	form	NOUN
dpc-4097	51	17	,	,	PUNCT
dpc-4097	51	18	two	two	NUM
dpc-4097	51	19	inverse	inverse	NOUN
dpc-4097	51	20	,	,	PUNCT
dpc-4097	51	21	six	six	NUM
dpc-4097	51	22	palmoplantar	palmoplantar	NOUN
dpc-4097	51	23	,	,	PUNCT
dpc-4097	51	24	five	five	NUM
dpc-4097	51	25	pustular	pustular	ADJ
dpc-4097	51	26	,	,	PUNCT
dpc-4097	51	27	and	and	CCONJ
dpc-4097	51	28	two	two	NUM
dpc-4097	51	29	erythrodermic	erythrodermic	NOUN
dpc-4097	51	30	;	;	PUNCT
dpc-4097	51	31	none	none	NOUN
dpc-4097	51	32	of	of	ADP
dpc-4097	51	33	the	the	DET
dpc-4097	51	34	124	124	NUM
dpc-4097	51	35	presented	present	VERB
dpc-4097	51	36	a	a	DET
dpc-4097	51	37	guttate	guttate	ADJ
dpc-4097	51	38	form	form	NOUN
dpc-4097	51	39	.	.	PUNCT
dpc-4097	52	1	of	of	ADP
dpc-4097	52	2	the	the	DET
dpc-4097	52	3	124	124	NUM
dpc-4097	52	4	patients	patient	NOUN
dpc-4097	52	5	,	,	PUNCT
dpc-4097	52	6	121	121	NUM
dpc-4097	52	7	(	(	PUNCT
dpc-4097	52	8	97,5	97,5	NUM
dpc-4097	52	9	%	%	NOUN
dpc-4097	52	10	)	)	PUNCT
dpc-4097	52	11	had	have	VERB
dpc-4097	52	12	localization	localization	NOUN
dpc-4097	52	13	in	in	ADP
dpc-4097	52	14	typical	typical	ADJ
dpc-4097	52	15	sites	site	NOUN
dpc-4097	52	16	:	:	PUNCT
dpc-4097	52	17	12	12	NUM
dpc-4097	52	18	in	in	ADP
dpc-4097	52	19	the	the	DET
dpc-4097	52	20	folds	fold	NOUN
dpc-4097	52	21	,	,	PUNCT
dpc-4097	52	22	17	17	NUM
dpc-4097	52	23	palmoplantar	palmoplantar	NOUN
dpc-4097	52	24	,	,	PUNCT
dpc-4097	52	25	19	19	NUM
dpc-4097	52	26	in	in	ADP
dpc-4097	52	27	nails	nail	NOUN
dpc-4097	52	28	,	,	PUNCT
dpc-4097	52	29	36	36	NUM
dpc-4097	52	30	on	on	ADP
dpc-4097	52	31	the	the	DET
dpc-4097	52	32	scalp	scalp	NOUN
dpc-4097	52	33	,	,	PUNCT
dpc-4097	52	34	and	and	CCONJ
dpc-4097	52	35	18	18	NUM
dpc-4097	52	36	in	in	ADP
dpc-4097	52	37	the	the	DET
dpc-4097	52	38	genital	genital	ADJ
dpc-4097	52	39	area	area	NOUN
dpc-4097	52	40	.	.	PUNCT
dpc-4097	53	1	of	of	ADP
dpc-4097	53	2	the	the	DET
dpc-4097	53	3	total	total	NOUN
dpc-4097	53	4	,	,	PUNCT
dpc-4097	53	5	54	54	NUM
dpc-4097	53	6	patients	patient	NOUN
dpc-4097	53	7	were	be	AUX
dpc-4097	53	8	not	not	PART
dpc-4097	53	9	taking	take	VERB
dpc-4097	53	10	any	any	DET
dpc-4097	53	11	home	home	NOUN
dpc-4097	53	12	therapy	therapy	NOUN
dpc-4097	53	13	,	,	PUNCT
dpc-4097	53	14	while	while	SCONJ
dpc-4097	53	15	41	41	NUM
dpc-4097	53	16	were	be	AUX
dpc-4097	53	17	on	on	ADP
dpc-4097	53	18	polypharmacotherapy	polypharmacotherapy	NOUN
dpc-4097	53	19	.	.	PUNCT
dpc-4097	54	1	only	only	ADV
dpc-4097	54	2	22	22	NUM
dpc-4097	54	3	patients	patient	NOUN
dpc-4097	54	4	were	be	AUX
dpc-4097	54	5	naive	naive	ADJ
dpc-4097	54	6	to	to	ADP
dpc-4097	54	7	biological	biological	ADJ
dpc-4097	54	8	therapy	therapy	NOUN
dpc-4097	54	9	,	,	PUNCT
dpc-4097	54	10	while	while	SCONJ
dpc-4097	54	11	of	of	ADP
dpc-4097	54	12	those	those	PRON
dpc-4097	54	13	who	who	PRON
dpc-4097	54	14	had	have	AUX
dpc-4097	54	15	already	already	ADV
dpc-4097	54	16	undergone	undergo	VERB
dpc-4097	54	17	previous	previous	ADJ
dpc-4097	54	18	treatments	treatment	NOUN
dpc-4097	54	19	,	,	PUNCT
dpc-4097	54	20	11	11	NUM
dpc-4097	54	21	had	have	AUX
dpc-4097	54	22	taken	take	VERB
dpc-4097	54	23	etanercept	etanercept	NOUN
dpc-4097	54	24	,	,	PUNCT
dpc-4097	54	25	48	48	NUM
dpc-4097	54	26	adalimumab	adalimumab	NOUN
dpc-4097	54	27	,	,	PUNCT
dpc-4097	54	28	13	13	NUM
dpc-4097	54	29	infliximab	infliximab	NOUN
dpc-4097	54	30	,	,	PUNCT
dpc-4097	54	31	two	two	NUM
dpc-4097	54	32	certolizumab	certolizumab	NOUN
dpc-4097	54	33	,	,	PUNCT
dpc-4097	54	34	35	35	NUM
dpc-4097	54	35	secukinumab	secukinumab	NOUN
dpc-4097	54	36	,	,	PUNCT
dpc-4097	54	37	eight	eight	NUM
dpc-4097	54	38	ixekizumab	ixekizumab	NOUN
dpc-4097	54	39	,	,	PUNCT
dpc-4097	54	40	18	18	NUM
dpc-4097	54	41	brodalumab	brodalumab	NOUN
dpc-4097	54	42	,	,	PUNCT
dpc-4097	54	43	four	four	NUM
dpc-4097	54	44	guselkumab	guselkumab	NOUN
dpc-4097	54	45	,	,	PUNCT
dpc-4097	54	46	two	two	NUM
dpc-4097	54	47	tildrakizumab	tildrakizumab	NOUN
dpc-4097	54	48	,	,	PUNCT
dpc-4097	54	49	and	and	CCONJ
dpc-4097	54	50	seven	seven	NUM
dpc-4097	54	51	apremilast	apremilast	ADJ
dpc-4097	54	52	,	,	PUNCT
dpc-4097	54	53	as	as	SCONJ
dpc-4097	54	54	reported	report	VERB
dpc-4097	54	55	in	in	ADP
dpc-4097	54	56	table	table	NOUN
dpc-4097	54	57	1	1	NUM
dpc-4097	54	58	.	.	PUNCT
dpc-4097	54	59	table	table	NOUN
dpc-4097	54	60	1	1	NUM
dpc-4097	54	61	.	.	PUNCT
dpc-4097	54	62	epidemiologic	epidemiologic	ADJ
dpc-4097	54	63	data	datum	NOUN
dpc-4097	54	64	about	about	ADP
dpc-4097	54	65	the	the	DET
dpc-4097	54	66	study	study	NOUN
dpc-4097	54	67	population	population	NOUN
dpc-4097	54	68	,	,	PUNCT
dpc-4097	54	69	body	body	NOUN
dpc-4097	54	70	sites	site	NOUN
dpc-4097	54	71	involved	involve	VERB
dpc-4097	54	72	and	and	CCONJ
dpc-4097	54	73	previous	previous	ADJ
dpc-4097	54	74	biologic	biologic	NOUN
dpc-4097	54	75	therapies	therapy	NOUN
dpc-4097	54	76	before	before	ADP
dpc-4097	54	77	administration	administration	NOUN
dpc-4097	54	78	of	of	ADP
dpc-4097	54	79	risankizumab	risankizumab	PROPN
dpc-4097	54	80	.	.	PUNCT
dpc-4097	55	1	study	study	NOUN
dpc-4097	55	2	population	population	NOUN
dpc-4097	55	3	no	no	INTJ
dpc-4097	55	4	.	.	PUNCT
dpc-4097	56	1	of	of	ADP
dpc-4097	56	2	patients	patient	NOUN
dpc-4097	56	3	total	total	VERB
dpc-4097	56	4	124	124	NUM
dpc-4097	56	5	males	male	NOUN
dpc-4097	56	6	72	72	NUM
dpc-4097	56	7	type	type	NOUN
dpc-4097	56	8	of	of	ADP
dpc-4097	56	9	psoriasis	psoriasis	NOUN
dpc-4097	56	10	no	no	INTJ
dpc-4097	56	11	.	.	PUNCT
dpc-4097	57	1	body	body	NOUN
dpc-4097	57	2	sites	site	NOUN
dpc-4097	57	3	involved	involve	VERB
dpc-4097	57	4	no	no	NOUN
dpc-4097	57	5	.	.	NOUN
dpc-4097	57	6	1	1	NUM
dpc-4097	57	7	:	:	PUNCT
dpc-4097	57	8	vulgar	vulgar	ADJ
dpc-4097	57	9	120	120	NUM
dpc-4097	57	10	1	1	NUM
dpc-4097	57	11	:	:	PUNCT
dpc-4097	57	12	typical	typical	ADJ
dpc-4097	57	13	sites	site	NOUN
dpc-4097	57	14	121	121	NUM
dpc-4097	57	15	2	2	NUM
dpc-4097	57	16	:	:	PUNCT
dpc-4097	57	17	inverse	inverse	NOUN
dpc-4097	57	18	2	2	NUM
dpc-4097	57	19	2	2	NUM
dpc-4097	57	20	:	:	PUNCT
dpc-4097	57	21	folds	fold	NOUN
dpc-4097	57	22	12	12	NUM
dpc-4097	57	23	3	3	NUM
dpc-4097	57	24	:	:	PUNCT
dpc-4097	57	25	palmo	palmo	NOUN
dpc-4097	57	26	-	-	NOUN
dpc-4097	57	27	plantar	plantar	NOUN
dpc-4097	57	28	6	6	NUM
dpc-4097	57	29	3	3	NUM
dpc-4097	57	30	:	:	PUNCT
dpc-4097	57	31	palmo	palmo	NOUN
dpc-4097	57	32	-	-	NOUN
dpc-4097	57	33	plantar	plantar	NOUN
dpc-4097	57	34	17	17	NUM
dpc-4097	57	35	4	4	NUM
dpc-4097	57	36	:	:	PUNCT
dpc-4097	57	37	pustular	pustular	ADJ
dpc-4097	57	38	5	5	NUM
dpc-4097	57	39	4	4	NUM
dpc-4097	57	40	:	:	PUNCT
dpc-4097	57	41	nails	nail	VERB
dpc-4097	57	42	19	19	NUM
dpc-4097	57	43	5	5	NUM
dpc-4097	57	44	:	:	PUNCT
dpc-4097	57	45	guttate	guttate	NOUN
dpc-4097	57	46	0	0	NUM
dpc-4097	57	47	5	5	NUM
dpc-4097	57	48	:	:	PUNCT
dpc-4097	57	49	scalp	scalp	NOUN
dpc-4097	57	50	36	36	NUM
dpc-4097	57	51	6	6	NUM
dpc-4097	57	52	:	:	PUNCT
dpc-4097	57	53	erythrodermic	erythrodermic	ADJ
dpc-4097	57	54	2	2	NUM
dpc-4097	57	55	6	6	NUM
dpc-4097	57	56	:	:	PUNCT
dpc-4097	57	57	genitals	genital	VERB
dpc-4097	57	58	18	18	NUM
dpc-4097	57	59	psoriatic	psoriatic	ADJ
dpc-4097	57	60	arthritis	arthritis	NOUN
dpc-4097	57	61	34	34	NUM
dpc-4097	57	62	epidemiologic	epidemiologic	ADJ
dpc-4097	57	63	data	datum	NOUN
dpc-4097	57	64	age	age	NOUN
dpc-4097	57	65	weight	weight	NOUN
dpc-4097	57	66	(	(	PUNCT
dpc-4097	57	67	kg	kg	NOUN
dpc-4097	57	68	)	)	PUNCT
dpc-4097	57	69	bmi	bmi	NOUN
dpc-4097	57	70	(	(	PUNCT
dpc-4097	57	71	kg	kg	NOUN
dpc-4097	57	72	/	/	SYM
dpc-4097	57	73	m2	m2	PROPN
dpc-4097	57	74	)	)	PUNCT
dpc-4097	57	75	duration	duration	NOUN
dpc-4097	57	76	of	of	ADP
dpc-4097	57	77	pso	pso	NOUN
dpc-4097	57	78	average	average	NOUN
dpc-4097	57	79	55.2016129	55.2016129	NUM
dpc-4097	57	80	82.72072072	82.72072072	NUM
dpc-4097	57	81	28.65911985	28.65911985	NUM
dpc-4097	57	82	21.27118644	21.27118644	NUM
dpc-4097	57	83	minimum	minimum	NOUN
dpc-4097	57	84	20	20	NUM
dpc-4097	57	85	50	50	NUM
dpc-4097	57	86	19	19	NUM
dpc-4097	57	87	1	1	NUM
dpc-4097	57	88	maximum	maximum	NOUN
dpc-4097	57	89	85	85	NUM
dpc-4097	57	90	140	140	NUM
dpc-4097	57	91	70	70	NUM
dpc-4097	57	92	53	53	NUM
dpc-4097	57	93	therapies	therapy	NOUN
dpc-4097	57	94	previous	previous	ADJ
dpc-4097	57	95	biologic	biologic	NOUN
dpc-4097	57	96	therapies	therapy	NOUN
dpc-4097	57	97	no	no	INTJ
dpc-4097	57	98	.	.	PUNCT
dpc-4097	58	1	concomitant	concomitant	ADJ
dpc-4097	58	2	therapies	therapy	NOUN
dpc-4097	58	3	no	no	INTJ
dpc-4097	59	1	.	.	PUNCT
dpc-4097	59	2	bio	bio	PROPN
dpc-4097	59	3	naive	naive	ADJ
dpc-4097	60	1	22	22	NUM
dpc-4097	60	2	none	none	NOUN
dpc-4097	60	3	54	54	NUM
dpc-4097	60	4	average	average	NOUN
dpc-4097	60	5	before	before	ADP
dpc-4097	60	6	risankizumab	risankizumab	NOUN
dpc-4097	60	7	1.61	1.61	NUM
dpc-4097	60	8	polytherapy	polytherapy	NOUN
dpc-4097	60	9	41	41	NUM
dpc-4097	60	10	etanercept	etanercept	VERB
dpc-4097	60	11	11	11	NUM
dpc-4097	60	12	adalimumab	adalimumab	NOUN
dpc-4097	60	13	48	48	NUM
dpc-4097	60	14	infliximab	infliximab	NOUN
dpc-4097	60	15	13	13	NUM
dpc-4097	60	16	certolizumab	certolizumab	NOUN
dpc-4097	60	17	2	2	NUM
dpc-4097	60	18	secukinumab	secukinumab	NOUN
dpc-4097	60	19	35	35	NUM
dpc-4097	60	20	ixekizumab	ixekizumab	NOUN
dpc-4097	60	21	8	8	NUM
dpc-4097	60	22	brodalumab	brodalumab	NOUN
dpc-4097	60	23	18	18	NUM
dpc-4097	60	24	guselkumab	guselkumab	NOUN
dpc-4097	60	25	4	4	NUM
dpc-4097	60	26	tildrakizumab	tildrakizumab	NOUN
dpc-4097	60	27	2	2	NUM
dpc-4097	60	28	risankizumab	risankizumab	NOUN
dpc-4097	60	29	19	19	NUM
dpc-4097	60	30	apremilast	apremilast	NOUN
dpc-4097	60	31	7	7	NUM
dpc-4097	60	32	bmi	bmi	NOUN
dpc-4097	60	33	=	=	SYM
dpc-4097	60	34	body	body	NOUN
dpc-4097	60	35	mass	mass	PROPN
dpc-4097	60	36	index	index	NOUN
dpc-4097	60	37	;	;	PUNCT
dpc-4097	60	38	pso	pso	NOUN
dpc-4097	60	39	=	=	NOUN
dpc-4097	60	40	psoriasis	psoriasis	NOUN
dpc-4097	60	41	.	.	PUNCT
dpc-4097	61	1	4	4	NUM
dpc-4097	61	2	original	original	ADJ
dpc-4097	61	3	article	article	NOUN
dpc-4097	61	4	|	|	ADV
dpc-4097	61	5	dermatol	dermatol	ADJ
dpc-4097	61	6	pract	pract	NOUN
dpc-4097	61	7	concept	concept	NOUN
dpc-4097	61	8	.	.	PUNCT
dpc-4097	62	1	2024;14(3):e2024171	2024;14(3):e2024171	NUM
dpc-4097	62	2	ustekinumab	ustekinumab	NOUN
dpc-4097	62	3	by	by	ADP
dpc-4097	62	4	body	body	NOUN
dpc-4097	62	5	region	region	NOUN
dpc-4097	62	6	,	,	PUNCT
dpc-4097	62	7	reported	report	VERB
dpc-4097	62	8	that	that	SCONJ
dpc-4097	62	9	the	the	DET
dpc-4097	62	10	mean	mean	ADJ
dpc-4097	62	11	pasi	pasi	NOUN
dpc-4097	62	12	scores	score	NOUN
dpc-4097	62	13	decreased	decrease	VERB
dpc-4097	62	14	at	at	ADP
dpc-4097	62	15	a	a	DET
dpc-4097	62	16	slower	slow	ADJ
dpc-4097	62	17	rate	rate	NOUN
dpc-4097	62	18	in	in	ADP
dpc-4097	62	19	the	the	DET
dpc-4097	62	20	lower	low	ADJ
dpc-4097	62	21	limbs	limb	NOUN
dpc-4097	62	22	compared	compare	VERB
dpc-4097	62	23	with	with	ADP
dpc-4097	62	24	other	other	ADJ
dpc-4097	62	25	body	body	NOUN
dpc-4097	62	26	regions	region	NOUN
dpc-4097	62	27	(	(	PUNCT
dpc-4097	62	28	head	head	NOUN
dpc-4097	62	29	and	and	CCONJ
dpc-4097	62	30	neck	neck	NOUN
dpc-4097	62	31	,	,	PUNCT
dpc-4097	62	32	trunk	trunk	NOUN
dpc-4097	62	33	,	,	PUNCT
dpc-4097	62	34	and	and	CCONJ
dpc-4097	62	35	upper	upper	ADJ
dpc-4097	62	36	limbs	limb	NOUN
dpc-4097	62	37	)	)	PUNCT
dpc-4097	62	38	in	in	ADP
dpc-4097	62	39	both	both	DET
dpc-4097	62	40	treatment	treatment	NOUN
dpc-4097	62	41	arms	arm	NOUN
dpc-4097	62	42	.	.	PUNCT
dpc-4097	63	1	additionally	additionally	ADV
dpc-4097	63	2	,	,	PUNCT
dpc-4097	63	3	the	the	DET
dpc-4097	63	4	time	time	NOUN
dpc-4097	63	5	needed	need	VERB
dpc-4097	63	6	to	to	PART
dpc-4097	63	7	achieve	achieve	VERB
dpc-4097	63	8	total	total	ADJ
dpc-4097	63	9	clearance	clearance	NOUN
dpc-4097	63	10	was	be	AUX
dpc-4097	63	11	shortest	short	ADJ
dpc-4097	63	12	for	for	ADP
dpc-4097	63	13	the	the	DET
dpc-4097	63	14	head	head	NOUN
dpc-4097	63	15	and	and	CCONJ
dpc-4097	63	16	neck	neck	NOUN
dpc-4097	63	17	regions	region	NOUN
dpc-4097	63	18	,	,	PUNCT
dpc-4097	63	19	followed	follow	VERB
dpc-4097	63	20	by	by	ADP
dpc-4097	63	21	that	that	PRON
dpc-4097	63	22	for	for	ADP
dpc-4097	63	23	the	the	DET
dpc-4097	63	24	trunk	trunk	NOUN
dpc-4097	63	25	and	and	CCONJ
dpc-4097	63	26	upper	upper	ADJ
dpc-4097	63	27	limbs	limb	NOUN
dpc-4097	63	28	.	.	PUNCT
dpc-4097	64	1	in	in	ADP
dpc-4097	64	2	contrast	contrast	NOUN
dpc-4097	64	3	,	,	PUNCT
dpc-4097	64	4	the	the	DET
dpc-4097	64	5	mean	mean	ADJ
dpc-4097	64	6	time	time	NOUN
dpc-4097	64	7	to	to	PART
dpc-4097	64	8	achieve	achieve	VERB
dpc-4097	64	9	total	total	ADJ
dpc-4097	64	10	clearance	clearance	NOUN
dpc-4097	64	11	was	be	AUX
dpc-4097	64	12	the	the	DET
dpc-4097	64	13	longest	long	ADJ
dpc-4097	64	14	in	in	ADP
dpc-4097	64	15	the	the	DET
dpc-4097	64	16	lower	low	ADJ
dpc-4097	64	17	limbs	limb	NOUN
dpc-4097	64	18	,	,	PUNCT
dpc-4097	64	19	supporting	support	VERB
dpc-4097	64	20	the	the	DET
dpc-4097	64	21	concept	concept	NOUN
dpc-4097	64	22	that	that	SCONJ
dpc-4097	64	23	lower	low	ADJ
dpc-4097	64	24	limbs	limb	NOUN
dpc-4097	64	25	are	be	AUX
dpc-4097	64	26	difficult	difficult	ADJ
dpc-4097	64	27	to	to	PART
dpc-4097	64	28	treat	treat	VERB
dpc-4097	64	29	and	and	CCONJ
dpc-4097	64	30	take	take	VERB
dpc-4097	64	31	longer	long	ADJ
dpc-4097	64	32	to	to	PART
dpc-4097	64	33	show	show	VERB
dpc-4097	64	34	a	a	DET
dpc-4097	64	35	therapeutic	therapeutic	ADJ
dpc-4097	64	36	response	response	NOUN
dpc-4097	64	37	.	.	PUNCT
dpc-4097	65	1	the	the	DET
dpc-4097	65	2	same	same	ADJ
dpc-4097	65	3	findings	finding	NOUN
dpc-4097	65	4	were	be	AUX
dpc-4097	65	5	also	also	ADV
dpc-4097	65	6	confirmed	confirm	VERB
dpc-4097	65	7	in	in	ADP
dpc-4097	65	8	50	50	NUM
dpc-4097	65	9	psoriatic	psoriatic	ADJ
dpc-4097	65	10	patients	patient	NOUN
dpc-4097	65	11	included	include	VERB
dpc-4097	65	12	in	in	ADP
dpc-4097	65	13	a	a	DET
dpc-4097	65	14	south	south	ADJ
dpc-4097	65	15	korean	korean	ADJ
dpc-4097	65	16	study	study	NOUN
dpc-4097	65	17	[	[	X
dpc-4097	65	18	11	11	NUM
dpc-4097	65	19	]	]	PUNCT
dpc-4097	65	20	:	:	PUNCT
dpc-4097	65	21	the	the	DET
dpc-4097	65	22	patients	patient	NOUN
dpc-4097	65	23	were	be	AUX
dpc-4097	65	24	treated	treat	VERB
dpc-4097	65	25	with	with	ADP
dpc-4097	65	26	biologics	biologic	NOUN
dpc-4097	65	27	for	for	ADP
dpc-4097	65	28	more	more	ADJ
dpc-4097	65	29	than	than	ADP
dpc-4097	65	30	six	six	NUM
dpc-4097	65	31	months	month	NOUN
dpc-4097	65	32	and	and	CCONJ
dpc-4097	65	33	exhibited	exhibit	VERB
dpc-4097	65	34	a	a	DET
dpc-4097	65	35	partial	partial	ADJ
dpc-4097	65	36	or	or	CCONJ
dpc-4097	65	37	good	good	ADJ
dpc-4097	65	38	response	response	NOUN
dpc-4097	65	39	(	(	PUNCT
dpc-4097	65	40	reaching	reach	VERB
dpc-4097	65	41	a	a	DET
dpc-4097	65	42	pasi	pasi	NOUN
dpc-4097	65	43	of	of	ADP
dpc-4097	65	44	1–5	1–5	NUM
dpc-4097	65	45	after	after	ADP
dpc-4097	65	46	biologics	biologics	NOUN
dpc-4097	65	47	treatment	treatment	NOUN
dpc-4097	65	48	)	)	PUNCT
dpc-4097	65	49	,	,	PUNCT
dpc-4097	65	50	and	and	CCONJ
dpc-4097	65	51	the	the	DET
dpc-4097	65	52	most	most	ADV
dpc-4097	65	53	common	common	ADJ
dpc-4097	65	54	biologics	biologic	NOUN
dpc-4097	65	55	-	-	PUNCT
dpc-4097	65	56	resistant	resistant	ADJ
dpc-4097	65	57	areas	area	NOUN
dpc-4097	65	58	were	be	AUX
dpc-4097	65	59	the	the	DET
dpc-4097	65	60	anterior	anterior	ADJ
dpc-4097	65	61	lower	low	ADJ
dpc-4097	65	62	leg	leg	NOUN
dpc-4097	65	63	(	(	PUNCT
dpc-4097	65	64	56.0	56.0	NUM
dpc-4097	65	65	%	%	NOUN
dpc-4097	65	66	)	)	PUNCT
dpc-4097	65	67	,	,	PUNCT
dpc-4097	65	68	followed	follow	VERB
dpc-4097	65	69	by	by	ADP
dpc-4097	65	70	the	the	DET
dpc-4097	65	71	knee	knee	NOUN
dpc-4097	65	72	(	(	PUNCT
dpc-4097	65	73	48.0	48.0	NUM
dpc-4097	65	74	%	%	NOUN
dpc-4097	65	75	)	)	PUNCT
dpc-4097	65	76	,	,	PUNCT
dpc-4097	65	77	and	and	CCONJ
dpc-4097	65	78	posterior	posterior	ADJ
dpc-4097	65	79	lower	low	ADJ
dpc-4097	65	80	leg	leg	NOUN
dpc-4097	65	81	(	(	PUNCT
dpc-4097	65	82	42.0	42.0	NUM
dpc-4097	65	83	%	%	NOUN
dpc-4097	65	84	)	)	PUNCT
dpc-4097	65	85	.	.	PUNCT
dpc-4097	66	1	in	in	ADP
dpc-4097	66	2	this	this	DET
dpc-4097	66	3	study	study	NOUN
dpc-4097	66	4	,	,	PUNCT
dpc-4097	66	5	the	the	DET
dpc-4097	66	6	biologics	biologic	NOUN
dpc-4097	66	7	included	include	VERB
dpc-4097	66	8	ustekinumab	ustekinumab	NOUN
dpc-4097	66	9	(	(	PUNCT
dpc-4097	66	10	n=16	n=16	NOUN
dpc-4097	66	11	,	,	PUNCT
dpc-4097	66	12	32.0	32.0	NUM
dpc-4097	66	13	%	%	NOUN
dpc-4097	66	14	)	)	PUNCT
dpc-4097	66	15	,	,	PUNCT
dpc-4097	66	16	secukinumab	secukinumab	NOUN
dpc-4097	66	17	(	(	PUNCT
dpc-4097	66	18	n=14	n=14	PROPN
dpc-4097	66	19	,	,	PUNCT
dpc-4097	66	20	28.0	28.0	NUM
dpc-4097	66	21	%	%	NOUN
dpc-4097	66	22	)	)	PUNCT
dpc-4097	66	23	,	,	PUNCT
dpc-4097	66	24	guselkumab	guselkumab	NOUN
dpc-4097	66	25	(	(	PUNCT
dpc-4097	66	26	n=12	n=12	PROPN
dpc-4097	66	27	,	,	PUNCT
dpc-4097	66	28	24.0	24.0	NUM
dpc-4097	66	29	%	%	NOUN
dpc-4097	66	30	)	)	PUNCT
dpc-4097	66	31	,	,	PUNCT
dpc-4097	66	32	ixekizumab	ixekizumab	NOUN
dpc-4097	66	33	(	(	PUNCT
dpc-4097	66	34	n=7	n=7	PROPN
dpc-4097	66	35	,	,	PUNCT
dpc-4097	66	36	14.0	14.0	NUM
dpc-4097	66	37	%	%	NOUN
dpc-4097	66	38	)	)	PUNCT
dpc-4097	66	39	,	,	PUNCT
dpc-4097	66	40	and	and	CCONJ
dpc-4097	66	41	adalimumab	adalimumab	NOUN
dpc-4097	66	42	(	(	PUNCT
dpc-4097	66	43	n=1	n=1	PROPN
dpc-4097	66	44	,	,	PUNCT
dpc-4097	66	45	2.0	2.0	NUM
dpc-4097	66	46	%	%	NOUN
dpc-4097	66	47	)	)	PUNCT
dpc-4097	66	48	.	.	PUNCT
dpc-4097	67	1	however	however	ADV
dpc-4097	67	2	,	,	PUNCT
dpc-4097	67	3	to	to	ADP
dpc-4097	67	4	date	date	NOUN
dpc-4097	67	5	,	,	PUNCT
dpc-4097	67	6	the	the	DET
dpc-4097	67	7	site	site	NOUN
dpc-4097	67	8	-	-	PUNCT
dpc-4097	67	9	specific	specific	ADJ
dpc-4097	67	10	effectiveness	effectiveness	NOUN
dpc-4097	67	11	of	of	ADP
dpc-4097	67	12	the	the	DET
dpc-4097	67	13	new	new	ADJ
dpc-4097	67	14	biologic	biologic	NOUN
dpc-4097	67	15	drug	drug	NOUN
dpc-4097	67	16	risankizumab	risankizumab	NOUN
dpc-4097	67	17	has	have	AUX
dpc-4097	67	18	not	not	PART
dpc-4097	67	19	been	be	AUX
dpc-4097	67	20	investigated	investigate	VERB
dpc-4097	67	21	in	in	ADP
dpc-4097	67	22	a	a	DET
dpc-4097	67	23	real	real	ADJ
dpc-4097	67	24	-	-	PUNCT
dpc-4097	67	25	world	world	NOUN
dpc-4097	67	26	setting	setting	NOUN
dpc-4097	67	27	.	.	PUNCT
dpc-4097	68	1	our	our	PRON
dpc-4097	68	2	retrospective	retrospective	ADJ
dpc-4097	68	3	multicenter	multicenter	NOUN
dpc-4097	68	4	study	study	NOUN
dpc-4097	68	5	enrolled	enrol	VERB
dpc-4097	68	6	a	a	DET
dpc-4097	68	7	cohort	cohort	NOUN
dpc-4097	68	8	of	of	ADP
dpc-4097	68	9	124	124	NUM
dpc-4097	68	10	patients	patient	NOUN
dpc-4097	68	11	with	with	ADP
dpc-4097	68	12	several	several	ADJ
dpc-4097	68	13	characteristics	characteristic	NOUN
dpc-4097	68	14	that	that	PRON
dpc-4097	68	15	are	be	AUX
dpc-4097	68	16	very	very	ADV
dpc-4097	68	17	the	the	DET
dpc-4097	68	18	difference	difference	NOUN
dpc-4097	68	19	between	between	ADP
dpc-4097	68	20	the	the	DET
dpc-4097	68	21	percentage	percentage	NOUN
dpc-4097	68	22	of	of	ADP
dpc-4097	68	23	improvement	improvement	NOUN
dpc-4097	68	24	compared	compare	VERB
dpc-4097	68	25	to	to	PART
dpc-4097	68	26	baseline	baseline	VERB
dpc-4097	68	27	of	of	ADP
dpc-4097	68	28	pasi	pasi	NOUN
dpc-4097	68	29	and	and	CCONJ
dpc-4097	68	30	leg	leg	NOUN
dpc-4097	68	31	-	-	PUNCT
dpc-4097	68	32	pasi	pasi	NOUN
dpc-4097	68	33	was	be	AUX
dpc-4097	68	34	statistically	statistically	ADV
dpc-4097	68	35	significant	significant	ADJ
dpc-4097	68	36	at	at	ADP
dpc-4097	68	37	16	16	NUM
dpc-4097	68	38	and	and	CCONJ
dpc-4097	68	39	28	28	NUM
dpc-4097	68	40	weeks	week	NOUN
dpc-4097	68	41	,	,	PUNCT
dpc-4097	68	42	demonstrating	demonstrate	VERB
dpc-4097	68	43	that	that	SCONJ
dpc-4097	68	44	leg	leg	NOUN
dpc-4097	68	45	-	-	PUNCT
dpc-4097	68	46	pasi	pasi	NOUN
dpc-4097	68	47	improved	improve	VERB
dpc-4097	68	48	less	less	ADV
dpc-4097	68	49	than	than	ADP
dpc-4097	68	50	pasi	pasi	NOUN
dpc-4097	68	51	at	at	ADP
dpc-4097	68	52	these	these	DET
dpc-4097	68	53	time	time	NOUN
dpc-4097	68	54	points	point	NOUN
dpc-4097	68	55	(	(	PUNCT
dpc-4097	68	56	figure	figure	NOUN
dpc-4097	68	57	1a	1a	NOUN
dpc-4097	68	58	)	)	PUNCT
dpc-4097	68	59	.	.	PUNCT
dpc-4097	69	1	from	from	ADP
dpc-4097	69	2	the	the	DET
dpc-4097	69	3	linear	linear	ADJ
dpc-4097	69	4	regression	regression	NOUN
dpc-4097	69	5	it	it	PRON
dpc-4097	69	6	can	can	AUX
dpc-4097	69	7	be	be	AUX
dpc-4097	69	8	clearly	clearly	ADV
dpc-4097	69	9	deduced	deduce	VERB
dpc-4097	69	10	that	that	SCONJ
dpc-4097	69	11	the	the	DET
dpc-4097	69	12	slope	slope	NOUN
dpc-4097	69	13	of	of	ADP
dpc-4097	69	14	the	the	DET
dpc-4097	69	15	line	line	NOUN
dpc-4097	69	16	is	be	AUX
dpc-4097	69	17	statistically	statistically	ADV
dpc-4097	69	18	less	less	ADV
dpc-4097	69	19	steep	steep	ADJ
dpc-4097	69	20	for	for	ADP
dpc-4097	69	21	leg	leg	NOUN
dpc-4097	69	22	-	-	PUNCT
dpc-4097	69	23	pasi	pasi	NOUN
dpc-4097	69	24	than	than	ADP
dpc-4097	69	25	for	for	ADP
dpc-4097	69	26	the	the	DET
dpc-4097	69	27	overall	overall	ADJ
dpc-4097	69	28	pasi	pasi	NOUN
dpc-4097	69	29	,	,	PUNCT
dpc-4097	69	30	confirming	confirm	VERB
dpc-4097	69	31	that	that	SCONJ
dpc-4097	69	32	this	this	DET
dpc-4097	69	33	site	site	NOUN
dpc-4097	69	34	responds	respond	VERB
dpc-4097	69	35	more	more	ADV
dpc-4097	69	36	slowly	slowly	ADV
dpc-4097	69	37	to	to	ADP
dpc-4097	69	38	the	the	DET
dpc-4097	69	39	therapy	therapy	NOUN
dpc-4097	69	40	,	,	PUNCT
dpc-4097	69	41	as	as	SCONJ
dpc-4097	69	42	reported	report	VERB
dpc-4097	69	43	in	in	ADP
dpc-4097	69	44	figure	figure	NOUN
dpc-4097	69	45	1b	1b	NUM
dpc-4097	69	46	.	.	PUNCT
dpc-4097	70	1	discussion	discussion	NOUN
dpc-4097	70	2	there	there	PRON
dpc-4097	70	3	is	be	VERB
dpc-4097	70	4	a	a	DET
dpc-4097	70	5	new	new	ADJ
dpc-4097	70	6	and	and	CCONJ
dpc-4097	70	7	growing	grow	VERB
dpc-4097	70	8	scientific	scientific	ADJ
dpc-4097	70	9	literature	literature	NOUN
dpc-4097	70	10	showing	show	VERB
dpc-4097	70	11	that	that	SCONJ
dpc-4097	70	12	lower	low	ADJ
dpc-4097	70	13	limbs	limb	NOUN
dpc-4097	70	14	are	be	AUX
dpc-4097	70	15	frequently	frequently	ADV
dpc-4097	70	16	severely	severely	ADV
dpc-4097	70	17	affected	affect	VERB
dpc-4097	70	18	in	in	ADP
dpc-4097	70	19	psoriatic	psoriatic	ADJ
dpc-4097	70	20	patients	patient	NOUN
dpc-4097	70	21	,	,	PUNCT
dpc-4097	70	22	representing	represent	VERB
dpc-4097	70	23	one	one	NUM
dpc-4097	70	24	of	of	ADP
dpc-4097	70	25	the	the	DET
dpc-4097	70	26	most	most	ADV
dpc-4097	70	27	difficult	difficult	ADJ
dpc-4097	70	28	-	-	PUNCT
dpc-4097	70	29	to	to	ADP
dpc-4097	70	30	-	-	PUNCT
dpc-4097	70	31	treat	treat	VERB
dpc-4097	70	32	regions	region	NOUN
dpc-4097	70	33	even	even	ADV
dpc-4097	70	34	in	in	ADP
dpc-4097	70	35	patients	patient	NOUN
dpc-4097	70	36	undergoing	undergo	VERB
dpc-4097	70	37	biological	biological	ADJ
dpc-4097	70	38	treatments	treatment	NOUN
dpc-4097	70	39	[	[	X
dpc-4097	70	40	9	9	NUM
dpc-4097	70	41	]	]	PUNCT
dpc-4097	70	42	.	.	PUNCT
dpc-4097	71	1	as	as	ADV
dpc-4097	71	2	early	early	ADV
dpc-4097	71	3	as	as	ADP
dpc-4097	71	4	2019	2019	NUM
dpc-4097	71	5	,	,	PUNCT
dpc-4097	71	6	hjuler	hjuler	NOUN
dpc-4097	71	7	et	et	NOUN
dpc-4097	71	8	al	al	PROPN
dpc-4097	71	9	.	.	PUNCT
dpc-4097	72	1	[	[	X
dpc-4097	72	2	5	5	NUM
dpc-4097	72	3	]	]	PUNCT
dpc-4097	72	4	investigated	investigate	VERB
dpc-4097	72	5	in	in	ADP
dpc-4097	72	6	146	146	NUM
dpc-4097	72	7	psoriatic	psoriatic	ADJ
dpc-4097	72	8	patients	patient	NOUN
dpc-4097	72	9	treated	treat	VERB
dpc-4097	72	10	for	for	ADP
dpc-4097	72	11	>	>	X
dpc-4097	72	12	6	6	NUM
dpc-4097	72	13	months	month	NOUN
dpc-4097	72	14	with	with	ADP
dpc-4097	72	15	biologic	biologic	NOUN
dpc-4097	72	16	agents	agent	NOUN
dpc-4097	72	17	the	the	DET
dpc-4097	72	18	location	location	NOUN
dpc-4097	72	19	of	of	ADP
dpc-4097	72	20	treatment	treatment	NOUN
dpc-4097	72	21	-	-	PUNCT
dpc-4097	72	22	resistant	resistant	ADJ
dpc-4097	72	23	disease	disease	NOUN
dpc-4097	72	24	;	;	PUNCT
dpc-4097	72	25	they	they	PRON
dpc-4097	72	26	found	find	VERB
dpc-4097	72	27	that	that	SCONJ
dpc-4097	72	28	the	the	DET
dpc-4097	72	29	most	most	ADV
dpc-4097	72	30	common	common	ADJ
dpc-4097	72	31	site	site	NOUN
dpc-4097	72	32	of	of	ADP
dpc-4097	72	33	recalcitrant	recalcitrant	ADJ
dpc-4097	72	34	psoriasis	psoriasis	NOUN
dpc-4097	72	35	was	be	AUX
dpc-4097	72	36	the	the	DET
dpc-4097	72	37	anterior	anterior	ADJ
dpc-4097	72	38	lower	low	ADJ
dpc-4097	72	39	leg	leg	NOUN
dpc-4097	73	1	[	[	X
dpc-4097	73	2	49	49	NUM
dpc-4097	73	3	,	,	PUNCT
dpc-4097	73	4	3	3	NUM
dpc-4097	73	5	%	%	NOUN
dpc-4097	73	6	;	;	PUNCT
dpc-4097	73	7	95	95	NUM
dpc-4097	73	8	%	%	NOUN
dpc-4097	73	9	confidence	confidence	NOUN
dpc-4097	73	10	interval	interval	NOUN
dpc-4097	73	11	(	(	PUNCT
dpc-4097	73	12	ci	ci	NOUN
dpc-4097	73	13	):	):	PUNCT
dpc-4097	73	14	41.2–57.4	41.2–57.4	NUM
dpc-4097	73	15	]	]	PUNCT
dpc-4097	73	16	.	.	PUNCT
dpc-4097	74	1	further	further	ADJ
dpc-4097	74	2	common	common	ADJ
dpc-4097	74	3	sites	site	NOUN
dpc-4097	74	4	of	of	ADP
dpc-4097	74	5	recalcitrant	recalcitrant	ADJ
dpc-4097	74	6	psoriasis	psoriasis	NOUN
dpc-4097	74	7	were	be	AUX
dpc-4097	74	8	the	the	DET
dpc-4097	74	9	posterior	posterior	ADJ
dpc-4097	74	10	lower	low	ADJ
dpc-4097	74	11	leg	leg	NOUN
dpc-4097	74	12	(	(	PUNCT
dpc-4097	74	13	24.7	24.7	NUM
dpc-4097	74	14	%	%	NOUN
dpc-4097	74	15	;	;	PUNCT
dpc-4097	74	16	95	95	NUM
dpc-4097	74	17	%	%	NOUN
dpc-4097	74	18	ci	ci	NOUN
dpc-4097	74	19	:	:	PUNCT
dpc-4097	74	20	17.7–31.6	17.7–31.6	NUM
dpc-4097	74	21	)	)	PUNCT
dpc-4097	74	22	,	,	PUNCT
dpc-4097	74	23	elbow	elbow	VERB
dpc-4097	74	24	(	(	PUNCT
dpc-4097	74	25	35.6	35.6	NUM
dpc-4097	74	26	%	%	NOUN
dpc-4097	74	27	;	;	PUNCT
dpc-4097	74	28	95	95	NUM
dpc-4097	74	29	%	%	NOUN
dpc-4097	74	30	ci	ci	NOUN
dpc-4097	74	31	:	:	PUNCT
dpc-4097	74	32	27.8–43.4	27.8–43.4	NOUN
dpc-4097	74	33	)	)	PUNCT
dpc-4097	74	34	,	,	PUNCT
dpc-4097	74	35	and	and	CCONJ
dpc-4097	74	36	the	the	DET
dpc-4097	74	37	scalp	scalp	NOUN
dpc-4097	74	38	(	(	PUNCT
dpc-4097	74	39	19.2	19.2	NUM
dpc-4097	74	40	%	%	NOUN
dpc-4097	74	41	;	;	PUNCT
dpc-4097	74	42	95	95	NUM
dpc-4097	74	43	%	%	NOUN
dpc-4097	74	44	ci	ci	NOUN
dpc-4097	74	45	:	:	PUNCT
dpc-4097	74	46	12.8–25.6	12.8–25.6	NUM
dpc-4097	74	47	%	%	NOUN
dpc-4097	74	48	)	)	PUNCT
dpc-4097	74	49	.	.	PUNCT
dpc-4097	75	1	in	in	ADP
dpc-4097	75	2	2022	2022	NUM
dpc-4097	75	3	,	,	PUNCT
dpc-4097	75	4	apalhao	apalhao	PROPN
dpc-4097	75	5	et	et	PROPN
dpc-4097	75	6	al	al	PROPN
dpc-4097	75	7	.	.	PUNCT
dpc-4097	76	1	[	[	X
dpc-4097	76	2	10	10	NUM
dpc-4097	76	3	]	]	PUNCT
dpc-4097	76	4	,	,	PUNCT
dpc-4097	76	5	in	in	ADP
dpc-4097	76	6	a	a	DET
dpc-4097	76	7	pooled	pooled	ADJ
dpc-4097	76	8	analysis	analysis	NOUN
dpc-4097	76	9	of	of	ADP
dpc-4097	76	10	clear	clear	ADJ
dpc-4097	76	11	and	and	CCONJ
dpc-4097	76	12	clarity	clarity	NOUN
dpc-4097	76	13	studies	study	NOUN
dpc-4097	76	14	of	of	ADP
dpc-4097	76	15	secukinumab	secukinumab	NOUN
dpc-4097	76	16	versus	versus	ADP
dpc-4097	76	17	figure	figure	NOUN
dpc-4097	76	18	1	1	NUM
dpc-4097	76	19	.	.	PUNCT
dpc-4097	77	1	(	(	PUNCT
dpc-4097	77	2	a	a	X
dpc-4097	77	3	)	)	PUNCT
dpc-4097	77	4	the	the	DET
dpc-4097	77	5	graphic	graphic	PROPN
dpc-4097	77	6	shows	show	VERB
dpc-4097	77	7	the	the	DET
dpc-4097	77	8	different	different	ADJ
dpc-4097	77	9	trend	trend	NOUN
dpc-4097	77	10	of	of	ADP
dpc-4097	77	11	pasi	pasi	NOUN
dpc-4097	77	12	and	and	CCONJ
dpc-4097	77	13	leg_pasi	leg_pasi	NOUN
dpc-4097	77	14	over	over	ADP
dpc-4097	77	15	time	time	NOUN
dpc-4097	77	16	from	from	ADP
dpc-4097	77	17	week	week	NOUN
dpc-4097	77	18	0	0	NUM
dpc-4097	77	19	to	to	ADP
dpc-4097	77	20	week	week	NOUN
dpc-4097	77	21	76	76	NUM
dpc-4097	77	22	.	.	PUNCT
dpc-4097	78	1	(	(	PUNCT
dpc-4097	78	2	b	b	X
dpc-4097	78	3	)	)	PUNCT
dpc-4097	78	4	linear	linear	ADJ
dpc-4097	78	5	regression	regression	NOUN
dpc-4097	78	6	shows	show	VERB
dpc-4097	78	7	that	that	SCONJ
dpc-4097	78	8	the	the	DET
dpc-4097	78	9	difference	difference	NOUN
dpc-4097	78	10	between	between	ADP
dpc-4097	78	11	pasi	pasi	NOUN
dpc-4097	78	12	and	and	CCONJ
dpc-4097	78	13	leg_pasi	leg_pasi	NOUN
dpc-4097	78	14	is	be	AUX
dpc-4097	78	15	statistically	statistically	ADV
dpc-4097	78	16	significant	significant	ADJ
dpc-4097	78	17	only	only	ADV
dpc-4097	78	18	up	up	ADP
dpc-4097	78	19	to	to	ADP
dpc-4097	78	20	week	week	NOUN
dpc-4097	78	21	28	28	NUM
dpc-4097	78	22	.	.	PUNCT
dpc-4097	79	1	original	original	ADJ
dpc-4097	79	2	article	article	NOUN
dpc-4097	79	3	|	|	ADV
dpc-4097	79	4	dermatol	dermatol	ADJ
dpc-4097	79	5	pract	pract	NOUN
dpc-4097	79	6	concept	concept	NOUN
dpc-4097	79	7	.	.	PUNCT
dpc-4097	80	1	2024;14(3):e2024171	2024;14(3):e2024171	NUM
dpc-4097	80	2	5	5	NUM
dpc-4097	80	3	references	reference	NOUN
dpc-4097	80	4	1	1	NUM
dpc-4097	80	5	.	.	PUNCT
dpc-4097	80	6	boehncke	boehncke	PROPN
dpc-4097	80	7	wh	wh	PROPN
dpc-4097	80	8	.	.	PUNCT
dpc-4097	81	1	systemic	systemic	ADJ
dpc-4097	81	2	inflammation	inflammation	NOUN
dpc-4097	81	3	and	and	CCONJ
dpc-4097	81	4	cardiovascular	cardiovascular	ADJ
dpc-4097	81	5	comorbidity	comorbidity	NOUN
dpc-4097	81	6	in	in	ADP
dpc-4097	81	7	psoriasis	psoriasis	NOUN
dpc-4097	81	8	patients	patient	NOUN
dpc-4097	81	9	:	:	PUNCT
dpc-4097	81	10	causes	cause	NOUN
dpc-4097	81	11	and	and	CCONJ
dpc-4097	81	12	consequences	consequence	NOUN
dpc-4097	81	13	.	.	PUNCT
dpc-4097	82	1	front	front	ADJ
dpc-4097	82	2	immunol	immunol	NOUN
dpc-4097	82	3	.	.	PUNCT
dpc-4097	83	1	5	5	NUM
dpc-4097	83	2	apr	apr	NOUN
dpc-4097	83	3	2018;9:579	2018;9:579	NUM
dpc-4097	83	4	.	.	PUNCT
dpc-4097	84	1	2	2	NUM
dpc-4097	84	2	.	.	X
dpc-4097	84	3	kragballe	kragballe	PROPN
dpc-4097	84	4	k.	k.	PROPN
dpc-4097	84	5	management	management	PROPN
dpc-4097	84	6	of	of	ADP
dpc-4097	84	7	difficult	difficult	ADJ
dpc-4097	84	8	to	to	PART
dpc-4097	84	9	treat	treat	VERB
dpc-4097	84	10	locations	location	NOUN
dpc-4097	84	11	of	of	ADP
dpc-4097	84	12	psoriasis	psoriasis	NOUN
dpc-4097	84	13	.	.	PUNCT
dpc-4097	85	1	scalp	scalp	NOUN
dpc-4097	85	2	,	,	PUNCT
dpc-4097	85	3	face	face	NOUN
dpc-4097	85	4	,	,	PUNCT
dpc-4097	85	5	flexures	flexure	NOUN
dpc-4097	85	6	,	,	PUNCT
dpc-4097	85	7	palm	palm	NOUN
dpc-4097	85	8	/	/	SYM
dpc-4097	85	9	soles	sol	NOUN
dpc-4097	85	10	and	and	CCONJ
dpc-4097	85	11	nails	nail	NOUN
dpc-4097	85	12	.	.	PUNCT
dpc-4097	86	1	curr	curr	PROPN
dpc-4097	86	2	probl	probl	PROPN
dpc-4097	86	3	dermatol	dermatol	NOUN
dpc-4097	86	4	.	.	PUNCT
dpc-4097	87	1	2009;38:160–71	2009;38:160–71	NUM
dpc-4097	87	2	.	.	PUNCT
dpc-4097	88	1	3	3	X
dpc-4097	88	2	.	.	X
dpc-4097	88	3	kivelevitch	kivelevitch	PROPN
dpc-4097	88	4	d	d	PROPN
dpc-4097	88	5	,	,	PUNCT
dpc-4097	88	6	frieder	frieder	PROPN
dpc-4097	88	7	j	j	PROPN
dpc-4097	88	8	,	,	PUNCT
dpc-4097	88	9	watson	watson	PROPN
dpc-4097	88	10	i	i	PROPN
dpc-4097	88	11	,	,	PUNCT
dpc-4097	88	12	paek	paek	PROPN
dpc-4097	88	13	sy	sy	PROPN
dpc-4097	88	14	,	,	PUNCT
dpc-4097	88	15	menter	menter	PROPN
dpc-4097	88	16	ma	ma	PROPN
dpc-4097	88	17	.	.	PROPN
dpc-4097	88	18	pharmacotherapeutic	pharmacotherapeutic	ADJ
dpc-4097	88	19	approaches	approach	NOUN
dpc-4097	88	20	for	for	ADP
dpc-4097	88	21	treating	treat	VERB
dpc-4097	88	22	psoriasis	psoriasis	NOUN
dpc-4097	88	23	in	in	ADP
dpc-4097	88	24	difficult	difficult	ADJ
dpc-4097	88	25	-	-	PUNCT
dpc-4097	88	26	to	to	ADP
dpc-4097	88	27	-	-	PUNCT
dpc-4097	88	28	treat	treat	NOUN
dpc-4097	88	29	areas	area	NOUN
dpc-4097	88	30	.	.	PUNCT
dpc-4097	89	1	expert	expert	NOUN
dpc-4097	89	2	opin	opin	NOUN
dpc-4097	89	3	pharmacother	pharmacother	NOUN
dpc-4097	89	4	.	.	PUNCT
dpc-4097	90	1	apr	apr	VERB
dpc-4097	90	2	2018;19(6):561–75	2018;19(6):561–75	NUM
dpc-4097	90	3	.	.	PUNCT
dpc-4097	91	1	4	4	NUM
dpc-4097	91	2	.	.	NOUN
dpc-4097	91	3	bardazzi	bardazzi	PROPN
dpc-4097	91	4	f	f	PROPN
dpc-4097	91	5	,	,	PUNCT
dpc-4097	91	6	viviani	viviani	PROPN
dpc-4097	91	7	f	f	PROPN
dpc-4097	91	8	,	,	PUNCT
dpc-4097	91	9	filippi	filippi	PROPN
dpc-4097	91	10	f	f	PROPN
dpc-4097	91	11	,	,	PUNCT
dpc-4097	91	12	carpanese	carpanese	PROPN
dpc-4097	91	13	ma	ma	PROPN
dpc-4097	91	14	,	,	PUNCT
dpc-4097	91	15	piraccini	piraccini	PROPN
dpc-4097	91	16	bm	bm	PROPN
dpc-4097	91	17	,	,	PUNCT
dpc-4097	91	18	abbenante	abbenante	ADV
dpc-4097	91	19	d.	d.	PROPN
dpc-4097	91	20	the	the	DET
dpc-4097	91	21	legs	leg	NOUN
dpc-4097	91	22	:	:	PUNCT
dpc-4097	91	23	an	an	DET
dpc-4097	91	24	underestimated	underestimated	ADJ
dpc-4097	91	25	difficult	difficult	ADJ
dpc-4097	91	26	-	-	PUNCT
dpc-4097	91	27	to	to	ADP
dpc-4097	91	28	-	-	PUNCT
dpc-4097	91	29	treat	treat	VERB
dpc-4097	91	30	area	area	NOUN
dpc-4097	91	31	of	of	ADP
dpc-4097	91	32	psoriasis	psoriasis	NOUN
dpc-4097	91	33	.	.	PUNCT
dpc-4097	92	1	dermatol	dermatol	NOUN
dpc-4097	92	2	ther	ther	ADV
dpc-4097	92	3	.	.	PUNCT
dpc-4097	93	1	june	june	PROPN
dpc-4097	93	2	2022;35(6):e15485	2022;35(6):e15485	NUM
dpc-4097	93	3	.	.	PROPN
dpc-4097	93	4	5	5	NUM
dpc-4097	93	5	.	.	X
dpc-4097	93	6	hjuler	hjuler	PROPN
dpc-4097	93	7	kf	kf	PROPN
dpc-4097	93	8	,	,	PUNCT
dpc-4097	93	9	iversen	iversen	PROPN
dpc-4097	93	10	l	l	PROPN
dpc-4097	93	11	,	,	PUNCT
dpc-4097	93	12	rasmussen	rasmussen	PROPN
dpc-4097	93	13	mk	mk	PROPN
dpc-4097	93	14	,	,	PUNCT
dpc-4097	93	15	kofoed	kofoed	PROPN
dpc-4097	93	16	k	k	PROPN
dpc-4097	93	17	,	,	PUNCT
dpc-4097	93	18	skov	skov	PROPN
dpc-4097	93	19	l	l	NOUN
dpc-4097	93	20	,	,	PUNCT
dpc-4097	93	21	zachariae	zachariae	PROPN
dpc-4097	93	22	c.	c.	PROPN
dpc-4097	93	23	localization	localization	NOUN
dpc-4097	93	24	of	of	ADP
dpc-4097	93	25	treatment	treatment	NOUN
dpc-4097	93	26	-	-	PUNCT
dpc-4097	93	27	resistant	resistant	ADJ
dpc-4097	93	28	areas	area	NOUN
dpc-4097	93	29	in	in	ADP
dpc-4097	93	30	patients	patient	NOUN
dpc-4097	93	31	with	with	ADP
dpc-4097	93	32	psoriasis	psoriasis	NOUN
dpc-4097	93	33	on	on	ADP
dpc-4097	93	34	biologics	biologic	NOUN
dpc-4097	93	35	.	.	PUNCT
dpc-4097	94	1	br	br	PROPN
dpc-4097	94	2	j	j	PROPN
dpc-4097	94	3	dermatol	dermatol	NOUN
dpc-4097	94	4	.	.	PUNCT
dpc-4097	95	1	aug	aug	PROPN
dpc-4097	95	2	2019;181(2):332–7	2019;181(2):332–7	NUM
dpc-4097	95	3	.	.	PUNCT
dpc-4097	96	1	6	6	NUM
dpc-4097	96	2	.	.	PUNCT
dpc-4097	97	1	katsuo	katsuo	PROPN
dpc-4097	97	2	k	k	PROPN
dpc-4097	97	3	,	,	PUNCT
dpc-4097	97	4	honda	honda	PROPN
dpc-4097	97	5	t	t	PROPN
dpc-4097	97	6	,	,	PUNCT
dpc-4097	97	7	kabashima	kabashima	PROPN
dpc-4097	97	8	k.	k.	PROPN
dpc-4097	97	9	improvement	improvement	NOUN
dpc-4097	97	10	of	of	ADP
dpc-4097	97	11	recalcitrant	recalcitrant	ADJ
dpc-4097	97	12	psoriatic	psoriatic	ADJ
dpc-4097	97	13	lesions	lesion	NOUN
dpc-4097	97	14	on	on	ADP
dpc-4097	97	15	the	the	DET
dpc-4097	97	16	lower	low	ADJ
dpc-4097	97	17	legs	leg	NOUN
dpc-4097	97	18	by	by	ADP
dpc-4097	97	19	changing	change	VERB
dpc-4097	97	20	the	the	DET
dpc-4097	97	21	injection	injection	NOUN
dpc-4097	97	22	site	site	NOUN
dpc-4097	97	23	of	of	ADP
dpc-4097	97	24	secukinumab	secukinumab	NOUN
dpc-4097	97	25	from	from	ADP
dpc-4097	97	26	the	the	DET
dpc-4097	97	27	abdomen	abdoman	NOUN
dpc-4097	97	28	to	to	ADP
dpc-4097	97	29	lower	low	ADJ
dpc-4097	97	30	legs	leg	NOUN
dpc-4097	97	31	.	.	PUNCT
dpc-4097	98	1	j	j	PROPN
dpc-4097	98	2	dermatol	dermatol	NOUN
dpc-4097	98	3	.	.	PUNCT
dpc-4097	99	1	feb	feb	PROPN
dpc-4097	99	2	2020;47(2):e54–5	2020;47(2):e54–5	NUM
dpc-4097	99	3	.	.	PUNCT
dpc-4097	100	1	7	7	NUM
dpc-4097	100	2	.	.	X
dpc-4097	100	3	murari	murari	PROPN
dpc-4097	100	4	a	a	PRON
dpc-4097	100	5	,	,	PUNCT
dpc-4097	100	6	singh	singh	PROPN
dpc-4097	100	7	kn	kn	PROPN
dpc-4097	100	8	.	.	PROPN
dpc-4097	100	9	lund	lund	PROPN
dpc-4097	100	10	and	and	CCONJ
dpc-4097	100	11	browder	browder	PROPN
dpc-4097	100	12	chart	chart	PROPN
dpc-4097	100	13	—	—	PUNCT
dpc-4097	100	14	modified	modify	VERB
dpc-4097	100	15	versus	versus	ADP
dpc-4097	100	16	original	original	ADJ
dpc-4097	100	17	:	:	PUNCT
dpc-4097	100	18	a	a	DET
dpc-4097	100	19	comparative	comparative	ADJ
dpc-4097	100	20	study	study	NOUN
dpc-4097	100	21	.	.	PUNCT
dpc-4097	101	1	acute	acute	PROPN
dpc-4097	101	2	crit	crit	PROPN
dpc-4097	101	3	care	care	NOUN
dpc-4097	101	4	.	.	PUNCT
dpc-4097	102	1	nov	nov	PROPN
dpc-4097	102	2	2019	2019	NUM
dpc-4097	102	3	;	;	PUNCT
dpc-4097	102	4	34(4):276–81	34(4):276–81	NUM
dpc-4097	102	5	.	.	NOUN
dpc-4097	102	6	8	8	NUM
dpc-4097	102	7	.	.	PUNCT
dpc-4097	102	8	montes	montes	PROPN
dpc-4097	102	9	de	de	PROPN
dpc-4097	102	10	oca	oca	PROPN
dpc-4097	102	11	pedrosa	pedrosa	PROPN
dpc-4097	102	12	a	a	PROPN
dpc-4097	102	13	,	,	PUNCT
dpc-4097	102	14	oakley	oakley	PROPN
dpc-4097	102	15	a	a	PRON
dpc-4097	102	16	,	,	PUNCT
dpc-4097	102	17	rogers	rogers	PROPN
dpc-4097	102	18	j	j	PROPN
dpc-4097	102	19	,	,	PUNCT
dpc-4097	102	20	rangaitaha	rangaitaha	PROPN
dpc-4097	102	21	epiha	epiha	PROPN
dpc-4097	102	22	m.	m.	NOUN
dpc-4097	102	23	pasi	pasi	PROPN
dpc-4097	102	24	vs	vs	ADP
dpc-4097	102	25	po	po	NOUN
dpc-4097	102	26	-	-	NOUN
dpc-4097	102	27	pasi	pasi	NOUN
dpc-4097	102	28	:	:	PUNCT
dpc-4097	102	29	patient	patient	NOUN
dpc-4097	102	30	-	-	PUNCT
dpc-4097	102	31	oriented	orient	VERB
dpc-4097	102	32	pasi	pasi	NOUN
dpc-4097	102	33	(	(	PUNCT
dpc-4097	102	34	po	po	NOUN
dpc-4097	102	35	-	-	NOUN
dpc-4097	102	36	pasi	pasi	NOUN
dpc-4097	102	37	)	)	PUNCT
dpc-4097	102	38	is	be	AUX
dpc-4097	102	39	comparable	comparable	ADJ
dpc-4097	102	40	to	to	ADP
dpc-4097	102	41	clinician	clinician	ADJ
dpc-4097	102	42	score	score	NOUN
dpc-4097	102	43	pasi	pasi	NOUN
dpc-4097	102	44	.	.	PUNCT
dpc-4097	103	1	australas	australas	PROPN
dpc-4097	103	2	j	j	PROPN
dpc-4097	103	3	dermatol	dermatol	PROPN
dpc-4097	103	4	.	.	PUNCT
dpc-4097	104	1	feb	feb	PROPN
dpc-4097	104	2	2022;63(1):e67–70	2022;63(1):e67–70	NUM
dpc-4097	104	3	.	.	PUNCT
dpc-4097	105	1	9	9	X
dpc-4097	105	2	.	.	X
dpc-4097	105	3	thaçi	thaçi	PROPN
dpc-4097	105	4	d	d	PROPN
dpc-4097	105	5	,	,	PUNCT
dpc-4097	105	6	blauvelt	blauvelt	VERB
dpc-4097	105	7	a	a	PRON
dpc-4097	105	8	,	,	PUNCT
dpc-4097	105	9	reich	reich	PROPN
dpc-4097	105	10	k	k	PROPN
dpc-4097	105	11	,	,	PUNCT
dpc-4097	105	12	et	et	PROPN
dpc-4097	105	13	al	al	PROPN
dpc-4097	105	14	.	.	PROPN
dpc-4097	105	15	secukinumab	secukinumab	PROPN
dpc-4097	105	16	is	be	AUX
dpc-4097	105	17	superior	superior	ADJ
dpc-4097	105	18	to	to	ADP
dpc-4097	105	19	ustekinumab	ustekinumab	NOUN
dpc-4097	105	20	in	in	ADP
dpc-4097	105	21	clearing	clear	VERB
dpc-4097	105	22	skin	skin	NOUN
dpc-4097	105	23	of	of	ADP
dpc-4097	105	24	subjects	subject	NOUN
dpc-4097	105	25	with	with	ADP
dpc-4097	105	26	moderate	moderate	ADJ
dpc-4097	105	27	to	to	ADP
dpc-4097	105	28	severe	severe	ADJ
dpc-4097	105	29	plaque	plaque	NOUN
dpc-4097	105	30	psoriasis	psoriasis	NOUN
dpc-4097	105	31	:	:	PUNCT
dpc-4097	105	32	clear	clear	ADJ
dpc-4097	105	33	,	,	PUNCT
dpc-4097	105	34	a	a	DET
dpc-4097	105	35	randomized	randomized	ADJ
dpc-4097	105	36	controlled	control	VERB
dpc-4097	105	37	trial	trial	NOUN
dpc-4097	105	38	.	.	PUNCT
dpc-4097	106	1	j	j	PROPN
dpc-4097	106	2	am	be	AUX
dpc-4097	106	3	acad	acad	ADJ
dpc-4097	106	4	dermatol	dermatol	NOUN
dpc-4097	106	5	.	.	PUNCT
dpc-4097	107	1	sept	sept	PROPN
dpc-4097	107	2	2015;73(3):400–9	2015;73(3):400–9	NUM
dpc-4097	107	3	.	.	PUNCT
dpc-4097	108	1	10	10	NUM
dpc-4097	108	2	.	.	PUNCT
dpc-4097	108	3	mastorino	mastorino	PROPN
dpc-4097	108	4	l	l	PROPN
dpc-4097	108	5	,	,	PUNCT
dpc-4097	108	6	susca	susca	PROPN
dpc-4097	108	7	s	s	PROPN
dpc-4097	108	8	,	,	PUNCT
dpc-4097	108	9	megna	megna	PROPN
dpc-4097	108	10	m	m	PROPN
dpc-4097	108	11	,	,	PUNCT
dpc-4097	108	12	et	et	PROPN
dpc-4097	108	13	al	al	PROPN
dpc-4097	108	14	.	.	PROPN
dpc-4097	108	15	risankizumabshows	risankizumabshow	VERB
dpc-4097	108	16	high	high	ADJ
dpc-4097	108	17	efficacy	efficacy	NOUN
dpc-4097	108	18	and	and	CCONJ
dpc-4097	108	19	maintenance	maintenance	NOUN
dpc-4097	108	20	in	in	ADP
dpc-4097	108	21	improvement	improvement	NOUN
dpc-4097	108	22	of	of	ADP
dpc-4097	108	23	response	response	NOUN
dpc-4097	108	24	until	until	ADP
dpc-4097	108	25	week	week	NOUN
dpc-4097	108	26	52	52	NUM
dpc-4097	108	27	.	.	PUNCT
dpc-4097	109	1	dermatol	dermatol	NOUN
dpc-4097	109	2	ther	ther	ADV
dpc-4097	109	3	.	.	PUNCT
dpc-4097	110	1	may	may	AUX
dpc-4097	110	2	2022;35(5):e15378	2022;35(5):e15378	NUM
dpc-4097	110	3	.	.	PROPN
dpc-4097	110	4	11	11	NUM
dpc-4097	110	5	.	.	PUNCT
dpc-4097	110	6	won	win	VERB
dpc-4097	110	7	sh	sh	PROPN
dpc-4097	110	8	,	,	PUNCT
dpc-4097	110	9	shin	shin	PROPN
dpc-4097	110	10	bs	bs	PROPN
dpc-4097	110	11	,	,	PUNCT
dpc-4097	110	12	bae	bae	PROPN
dpc-4097	110	13	kn	kn	PROPN
dpc-4097	110	14	,	,	PUNCT
dpc-4097	110	15	et	et	PROPN
dpc-4097	110	16	al	al	PROPN
dpc-4097	110	17	.	.	PROPN
dpc-4097	111	1	which	which	DET
dpc-4097	111	2	areas	area	NOUN
dpc-4097	111	3	are	be	AUX
dpc-4097	111	4	still	still	ADV
dpc-4097	111	5	left	leave	VERB
dpc-4097	111	6	in	in	ADP
dpc-4097	111	7	biologics	biologic	NOUN
dpc-4097	111	8	responsive	responsive	ADJ
dpc-4097	111	9	korean	korean	ADJ
dpc-4097	111	10	patients	patient	NOUN
dpc-4097	111	11	with	with	ADP
dpc-4097	111	12	moderate	moderate	ADJ
dpc-4097	111	13	to	to	ADP
dpc-4097	111	14	severe	severe	ADJ
dpc-4097	111	15	plaque	plaque	NOUN
dpc-4097	111	16	psoriasis	psoriasis	NOUN
dpc-4097	111	17	.	.	PUNCT
dpc-4097	112	1	ann	ann	PROPN
dpc-4097	112	2	dermatol	dermatol	NOUN
dpc-4097	112	3	.	.	PUNCT
dpc-4097	113	1	feb	feb	PROPN
dpc-4097	113	2	2023;35(1):6–10	2023;35(1):6–10	NOUN
dpc-4097	113	3	.	.	PUNCT
dpc-4097	114	1	common	common	ADJ
dpc-4097	114	2	in	in	ADP
dpc-4097	114	3	a	a	DET
dpc-4097	114	4	real	real	ADJ
dpc-4097	114	5	-	-	PUNCT
dpc-4097	114	6	life	life	NOUN
dpc-4097	114	7	setting	setting	NOUN
dpc-4097	114	8	of	of	ADP
dpc-4097	114	9	specialized	specialized	ADJ
dpc-4097	114	10	clinics	clinic	NOUN
dpc-4097	114	11	for	for	ADP
dpc-4097	114	12	the	the	DET
dpc-4097	114	13	care	care	NOUN
dpc-4097	114	14	of	of	ADP
dpc-4097	114	15	complex	complex	ADJ
dpc-4097	114	16	psoriasis	psoriasis	NOUN
dpc-4097	114	17	patients	patient	NOUN
dpc-4097	114	18	,	,	PUNCT
dpc-4097	114	19	represented	represent	VERB
dpc-4097	114	20	by	by	ADP
dpc-4097	114	21	a	a	DET
dpc-4097	114	22	high	high	ADJ
dpc-4097	114	23	average	average	ADJ
dpc-4097	114	24	age	age	NOUN
dpc-4097	114	25	(	(	PUNCT
dpc-4097	114	26	55.2	55.2	NUM
dpc-4097	114	27	years	year	NOUN
dpc-4097	114	28	)	)	PUNCT
dpc-4097	114	29	,	,	PUNCT
dpc-4097	114	30	bio	bio	ADJ
dpc-4097	114	31	-	-	ADJ
dpc-4097	114	32	experienced	experienced	ADJ
dpc-4097	114	33	status	status	NOUN
dpc-4097	114	34	(	(	PUNCT
dpc-4097	114	35	82.3	82.3	NUM
dpc-4097	114	36	%	%	NOUN
dpc-4097	114	37	)	)	PUNCT
dpc-4097	114	38	,	,	PUNCT
dpc-4097	114	39	a	a	DET
dpc-4097	114	40	high	high	ADJ
dpc-4097	114	41	bmi	bmi	NOUN
dpc-4097	114	42	(	(	PUNCT
dpc-4097	114	43	28.7	28.7	NUM
dpc-4097	114	44	)	)	PUNCT
dpc-4097	114	45	,	,	PUNCT
dpc-4097	114	46	and	and	CCONJ
dpc-4097	114	47	a	a	DET
dpc-4097	114	48	high	high	ADJ
dpc-4097	114	49	number	number	NOUN
dpc-4097	114	50	of	of	ADP
dpc-4097	114	51	comorbidities	comorbiditie	NOUN
dpc-4097	114	52	that	that	PRON
dpc-4097	114	53	require	require	VERB
dpc-4097	114	54	multiple	multiple	ADJ
dpc-4097	114	55	concomitant	concomitant	ADJ
dpc-4097	114	56	medications	medication	NOUN
dpc-4097	114	57	(	(	PUNCT
dpc-4097	114	58	56.5	56.5	NUM
dpc-4097	114	59	%	%	NOUN
dpc-4097	114	60	)	)	PUNCT
dpc-4097	114	61	.	.	PUNCT
dpc-4097	115	1	the	the	DET
dpc-4097	115	2	analysis	analysis	NOUN
dpc-4097	115	3	of	of	ADP
dpc-4097	115	4	our	our	PRON
dpc-4097	115	5	cohort	cohort	NOUN
dpc-4097	115	6	of	of	ADP
dpc-4097	115	7	patients	patient	NOUN
dpc-4097	115	8	demonstrated	demonstrate	VERB
dpc-4097	115	9	that	that	SCONJ
dpc-4097	115	10	legs	leg	NOUN
dpc-4097	115	11	improved	improve	VERB
dpc-4097	115	12	significantly	significantly	ADV
dpc-4097	115	13	less	less	ADJ
dpc-4097	115	14	than	than	ADP
dpc-4097	115	15	the	the	DET
dpc-4097	115	16	rest	rest	NOUN
dpc-4097	115	17	of	of	ADP
dpc-4097	115	18	the	the	DET
dpc-4097	115	19	body	body	NOUN
dpc-4097	115	20	between	between	ADP
dpc-4097	115	21	weeks	week	NOUN
dpc-4097	115	22	16	16	NUM
dpc-4097	115	23	and	and	CCONJ
dpc-4097	115	24	28	28	NUM
dpc-4097	115	25	,	,	PUNCT
dpc-4097	115	26	and	and	CCONJ
dpc-4097	115	27	from	from	ADP
dpc-4097	115	28	the	the	DET
dpc-4097	115	29	statistical	statistical	ADJ
dpc-4097	115	30	linear	linear	NOUN
dpc-4097	115	31	regression	regression	NOUN
dpc-4097	115	32	showed	show	VERB
dpc-4097	115	33	that	that	SCONJ
dpc-4097	115	34	this	this	DET
dpc-4097	115	35	site	site	NOUN
dpc-4097	115	36	responded	respond	VERB
dpc-4097	115	37	more	more	ADV
dpc-4097	115	38	slowly	slowly	ADV
dpc-4097	115	39	to	to	ADP
dpc-4097	115	40	the	the	DET
dpc-4097	115	41	therapy	therapy	NOUN
dpc-4097	115	42	.	.	PUNCT
dpc-4097	116	1	thus	thus	ADV
dpc-4097	116	2	,	,	PUNCT
dpc-4097	116	3	this	this	DET
dpc-4097	116	4	new	new	ADJ
dpc-4097	116	5	biologic	biologic	NOUN
dpc-4097	116	6	drug	drug	NOUN
dpc-4097	116	7	does	do	AUX
dpc-4097	116	8	not	not	PART
dpc-4097	116	9	appear	appear	VERB
dpc-4097	116	10	to	to	PART
dpc-4097	116	11	differ	differ	VERB
dpc-4097	116	12	significantly	significantly	ADV
dpc-4097	116	13	from	from	ADP
dpc-4097	116	14	previous	previous	ADJ
dpc-4097	116	15	ones	one	NOUN
dpc-4097	116	16	with	with	ADP
dpc-4097	116	17	regard	regard	NOUN
dpc-4097	116	18	to	to	ADP
dpc-4097	116	19	site	site	NOUN
dpc-4097	116	20	-	-	PUNCT
dpc-4097	116	21	specific	specific	ADJ
dpc-4097	116	22	response	response	NOUN
dpc-4097	116	23	in	in	ADP
dpc-4097	116	24	the	the	DET
dpc-4097	116	25	first	first	ADJ
dpc-4097	116	26	few	few	ADJ
dpc-4097	116	27	weeks	week	NOUN
dpc-4097	116	28	of	of	ADP
dpc-4097	116	29	treatment	treatment	NOUN
dpc-4097	116	30	.	.	PUNCT
dpc-4097	117	1	however	however	ADV
dpc-4097	117	2	,	,	PUNCT
dpc-4097	117	3	although	although	SCONJ
dpc-4097	117	4	the	the	DET
dpc-4097	117	5	legs	leg	NOUN
dpc-4097	117	6	are	be	AUX
dpc-4097	117	7	confirmed	confirm	VERB
dpc-4097	117	8	to	to	PART
dpc-4097	117	9	be	be	AUX
dpc-4097	117	10	a	a	DET
dpc-4097	117	11	difficult	difficult	ADJ
dpc-4097	117	12	-	-	PUNCT
dpc-4097	117	13	to	to	ADP
dpc-4097	117	14	-	-	PUNCT
dpc-4097	117	15	treat	treat	NOUN
dpc-4097	117	16	area	area	NOUN
dpc-4097	117	17	,	,	PUNCT
dpc-4097	117	18	after	after	ADP
dpc-4097	117	19	28	28	NUM
dpc-4097	117	20	weeks	week	NOUN
dpc-4097	117	21	,	,	PUNCT
dpc-4097	117	22	the	the	DET
dpc-4097	117	23	statistical	statistical	ADJ
dpc-4097	117	24	significance	significance	NOUN
dpc-4097	117	25	was	be	AUX
dpc-4097	117	26	lost	lose	VERB
dpc-4097	117	27	,	,	PUNCT
dpc-4097	117	28	and	and	CCONJ
dpc-4097	117	29	the	the	DET
dpc-4097	117	30	legs	leg	NOUN
dpc-4097	117	31	began	begin	VERB
dpc-4097	117	32	to	to	PART
dpc-4097	117	33	respond	respond	VERB
dpc-4097	117	34	like	like	ADP
dpc-4097	117	35	the	the	DET
dpc-4097	117	36	other	other	ADJ
dpc-4097	117	37	body	body	NOUN
dpc-4097	117	38	sites	site	NOUN
dpc-4097	117	39	.	.	PUNCT
dpc-4097	118	1	limitations	limitation	NOUN
dpc-4097	118	2	the	the	DET
dpc-4097	118	3	limitations	limitation	NOUN
dpc-4097	118	4	of	of	ADP
dpc-4097	118	5	our	our	PRON
dpc-4097	118	6	study	study	NOUN
dpc-4097	118	7	were	be	AUX
dpc-4097	118	8	its	its	PRON
dpc-4097	118	9	retrospective	retrospective	ADJ
dpc-4097	118	10	design	design	NOUN
dpc-4097	118	11	and	and	CCONJ
dpc-4097	118	12	its	its	PRON
dpc-4097	118	13	multicenter	multicenter	ADJ
dpc-4097	118	14	nature	nature	NOUN
dpc-4097	118	15	.	.	PUNCT
dpc-4097	119	1	conclusions	conclusion	NOUN
dpc-4097	119	2	our	our	PRON
dpc-4097	119	3	preliminary	preliminary	ADJ
dpc-4097	119	4	finding	finding	NOUN
dpc-4097	119	5	suggests	suggest	VERB
dpc-4097	119	6	that	that	SCONJ
dpc-4097	119	7	risankizumab	risankizumab	NOUN
dpc-4097	119	8	can	can	AUX
dpc-4097	119	9	be	be	AUX
dpc-4097	119	10	considered	consider	VERB
dpc-4097	119	11	an	an	DET
dpc-4097	119	12	effective	effective	ADJ
dpc-4097	119	13	drug	drug	NOUN
dpc-4097	119	14	in	in	ADP
dpc-4097	119	15	this	this	DET
dpc-4097	119	16	body	body	NOUN
dpc-4097	119	17	region	region	NOUN
dpc-4097	119	18	,	,	PUNCT
dpc-4097	119	19	with	with	ADP
dpc-4097	119	20	longer	long	ADJ
dpc-4097	119	21	response	response	NOUN
dpc-4097	119	22	time	time	NOUN
dpc-4097	119	23	than	than	ADP
dpc-4097	119	24	in	in	ADP
dpc-4097	119	25	other	other	ADJ
dpc-4097	119	26	affected	affected	ADJ
dpc-4097	119	27	body	body	NOUN
dpc-4097	119	28	areas	area	NOUN
dpc-4097	119	29	,	,	PUNCT
dpc-4097	119	30	demonstrating	demonstrate	VERB
dpc-4097	119	31	the	the	DET
dpc-4097	119	32	relative	relative	ADJ
dpc-4097	119	33	treatment	treatment	NOUN
dpc-4097	119	34	resistance	resistance	NOUN
dpc-4097	119	35	nature	nature	NOUN
dpc-4097	119	36	of	of	ADP
dpc-4097	119	37	this	this	DET
dpc-4097	119	38	district	district	NOUN
dpc-4097	119	39	.	.	PUNCT
dpc-4097	120	1	overall	overall	ADV
dpc-4097	120	2	,	,	PUNCT
dpc-4097	120	3	our	our	PRON
dpc-4097	120	4	findings	finding	NOUN
dpc-4097	120	5	highlight	highlight	VERB
dpc-4097	120	6	that	that	SCONJ
dpc-4097	120	7	the	the	DET
dpc-4097	120	8	lower	low	ADJ
dpc-4097	120	9	limbs	limb	NOUN
dpc-4097	120	10	can	can	AUX
dpc-4097	120	11	take	take	VERB
dpc-4097	120	12	longer	long	ADJ
dpc-4097	120	13	to	to	PART
dpc-4097	120	14	respond	respond	VERB
dpc-4097	120	15	,	,	PUNCT
dpc-4097	120	16	but	but	CCONJ
dpc-4097	120	17	in	in	ADP
dpc-4097	120	18	patients	patient	NOUN
dpc-4097	120	19	undergoing	undergo	VERB
dpc-4097	120	20	risankizumab	risankizumab	NOUN
dpc-4097	120	21	therapy	therapy	NOUN
dpc-4097	120	22	,	,	PUNCT
dpc-4097	120	23	a	a	DET
dpc-4097	120	24	further	further	ADJ
dpc-4097	120	25	grade	grade	NOUN
dpc-4097	120	26	of	of	ADP
dpc-4097	120	27	response	response	NOUN
dpc-4097	120	28	is	be	AUX
dpc-4097	120	29	possible	possible	ADJ
dpc-4097	120	30	even	even	ADV
dpc-4097	120	31	beyond	beyond	ADP
dpc-4097	120	32	six	six	NUM
dpc-4097	120	33	months	month	NOUN
dpc-4097	120	34	.	.	PUNCT
dpc-4097	121	1	this	this	DET
dpc-4097	121	2	finding	finding	NOUN
dpc-4097	121	3	,	,	PUNCT
dpc-4097	121	4	although	although	SCONJ
dpc-4097	121	5	preliminary	preliminary	ADJ
dpc-4097	121	6	and	and	CCONJ
dpc-4097	121	7	observed	observe	VERB
dpc-4097	121	8	in	in	ADP
dpc-4097	121	9	a	a	DET
dpc-4097	121	10	small	small	ADJ
dpc-4097	121	11	cohort	cohort	NOUN
dpc-4097	121	12	,	,	PUNCT
dpc-4097	121	13	may	may	AUX
dpc-4097	121	14	be	be	AUX
dpc-4097	121	15	of	of	ADP
dpc-4097	121	16	reassurance	reassurance	NOUN
dpc-4097	121	17	to	to	ADP
dpc-4097	121	18	patients	patient	NOUN
dpc-4097	121	19	.	.	PUNCT